Acadia Healthcare (ACHC) 10-Q 5 Aug 15 2015 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 05, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2
Trading Symbol	ACHC
Entity Registrant Name	Acadia Healthcare Company, Inc.
Entity Central Index Key	1,520,697
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		71,637,097

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 34,572	$ 94,040
Accounts receivable, net of allowance for doubtful accounts of $26,233 and $22,449, respectively	182,315	118,378
Deferred tax assets	38,693	20,155
Other current assets	70,325	41,570
Total current assets	325,905	274,143
Property and equipment, net	1,455,390	1,069,700
Goodwill	1,946,028	802,986
Intangible assets, net	58,514	21,636
Deferred tax assets - noncurrent	33,966	13,141
Other assets	106,582	41,984
Total assets	3,926,385	2,223,590
Current liabilities:
Current portion of long-term debt	38,652	26,965
Accounts payable	58,714	48,696
Accrued salaries and benefits	77,545	59,317
Other accrued liabilities	68,197	30,956
Total current liabilities	243,108	165,934
Long-term debt	1,914,555	1,069,305
Deferred tax liabilities - noncurrent	20,200	63,880
Other liabilities	82,218	43,506
Total liabilities	$ 2,260,081	$ 1,342,625
Equity:
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued
Common stock, $0.01 par value; 90,000,000 shares authorized; 70,596,523 and 59,211,859 issued and outstanding as of June 30, 2015 and December 31, 2014, respectively	$ 706	$ 592
Additional paid-in capital	1,567,304	847,301
Accumulated other comprehensive loss	(51,586)	(68,370)
Retained earnings	149,880	101,442
Total equity	1,666,304	880,965
Total liabilities and equity	$ 3,926,385	$ 2,223,590

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Receivable, allowance for doubtful accounts	$ 26,233	$ 22,449
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	10,000,000	10,000,000
Preferred stock, issued	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	90,000,000	90,000,000
Common stock, shares issued	70,596,523	59,211,859
Common stock, shares outstanding	70,596,523	59,211,859

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Income Statement [Abstract]
Revenue before provision for doubtful accounts	$ 461,798	$ 220,664	$ 835,956	$ 426,783
Provision for doubtful accounts	(8,138)	(6,861)	(16,513)	(11,562)
Revenue	453,660	213,803	819,443	415,221
Salaries, wages and benefits (including equity-based compensation expense of $5,355, $2,406, $9,249 and $4,170, respectively)	243,302	122,473	449,173	240,048
Professional fees	30,029	10,891	52,456	21,273
Supplies	20,542	10,596	36,796	20,660
Rents and leases	8,211	2,889	14,097	5,658
Other operating expenses	51,128	24,646	91,655	47,756
Depreciation and amortization	14,926	5,935	28,030	11,371
Interest expense, net	28,049	9,730	50,195	19,437
Loss (gain) on foreign currency derivatives	961	(13,735)	908	(13,735)
Transaction-related expenses	7,157	3,016	25,573	4,595
Total expenses	404,305	176,441	748,883	357,063
Income from continuing operations before income taxes	49,355	37,362	70,560	58,158
Provision for income taxes	15,512	14,905	22,125	22,680
Income (loss) from continuing operations	33,843	22,457	48,435	35,478
Income (loss) from discontinued operations, net of income taxes	1	(6)	3	31
Net income	$ 33,844	$ 22,451	$ 48,438	$ 35,509
Basic earnings per share:
Income from continuing operations	$ 0.50	$ 0.43	$ 0.74	$ 0.70
Income (loss) from discontinued operations	0	0	0	0
Net income	0.50	0.43	0.74	0.70
Diluted earnings per share:
Income from continuing operations	0.49	0.43	0.74	0.69
Income (loss) from discontinued operations	0	0	0	0
Net income	$ 0.49	$ 0.43	$ 0.74	$ 0.69
Weighted-average shares outstanding:
Basic	68,296	51,616	65,429	50,872
Diluted	68,735	51,819	65,782	51,174

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Income Statement [Abstract]
Equity-based compensation expense	$ 5,355	$ 2,406	$ 9,249	$ 4,170

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Statement of Comprehensive Income [Abstract]
Net income	$ 33,844	$ 22,451	$ 48,438	$ 35,509
Other comprehensive income:
Foreign currency translation gain	46,173		16,784
Other comprehensive income	46,173		16,784
Comprehensive income	$ 80,017	$ 22,451	$ 65,222	$ 35,509

Condensed Consolidated Stateme7

Condensed Consolidated Statement of Equity (Unaudited) - 6 months ended Jun. 30, 2015 - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Other Comprehensive Loss [Member]	Retained Earnings (Accumulated Deficit) [Member]
Balance at Dec. 31, 2014	$ 880,965	$ 592	$ 847,301	$ (68,370)	$ 101,442
Balance, shares at Dec. 31, 2014	59,211,859	59,212
Common stock issued under stock incentive plans		$ 2	(2)
Common stock issued under stock incentive plans, shares	49,045	234,000
Common stock withheld for minimum statutory taxes	$ (7,826)		(7,826)
Equity-based compensation expense	9,249		9,249
Excess tax benefit from equity awards	6,327		6,327
Issuance of common stock, net	711,740	$ 112	711,628
Issuance of common stock, net, shares		11,150,000
Other comprehensive loss	16,784			16,784
Other	627		627
Net income	48,438				48,438
Balance at Jun. 30, 2015	$ 1,666,304	$ 706	$ 1,567,304	$ (51,586)	$ 149,880
Balance, shares at Jun. 30, 2015	70,596,523	70,596

Condensed Consolidated Stateme8

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Operating activities:
Net income	$ 48,438	$ 35,509
Adjustments to reconcile net income to net cash provided by continuing operating activities:
Depreciation and amortization	28,030	11,371
Amortization of debt issuance costs	3,218	1,334
Equity-based compensation expense	9,249	4,170
Deferred income tax expense	24,682	9,097
Income from discontinued operations, net of taxes	(3)	(31)
Loss (gain) on foreign currency derivatives	908	(13,735)
Other	692	25
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	(10,442)	(15,303)
Other current assets	(13,048)	(4,792)
Other assets	(1,218)	(578)
Accounts payable and other accrued liabilities	(4,313)	(1,300)
Accrued salaries and benefits	(225)	1,782
Other liabilities	4,619	1,701
Net cash provided by continuing operating activities	90,587	29,250
Net cash provided by (used in) discontinued operating activities	554	(11)
Net cash provided by operating activities	91,141	29,239
Investing activities:
Cash paid for acquisitions, net of cash acquired	(286,734)	(10,000)
Cash paid for capital expenditures	(122,035)	(43,323)
Cash paid for real estate acquisitions	(3,428)	(18,326)
Settlement of foreign currency derivatives	(908)
Other	(481)	(439)
Net cash used in investing activities	(413,586)	(72,088)
Financing activities:
Borrowings on long-term debt	875,000	7,500
Borrowings on revolving credit facility	180,000	59,500
Principal payments revolving credit facility	(180,000)	(113,000)
Principal payments on long-term debt	(15,875)	(3,750)
Repayment of assumed CRC debt	(904,467)
Payment of debt issuance costs	(22,775)	(5,810)
Issuance of common stock, net	331,530	374,336
Common stock withheld for minimum statutory taxes, net	(7,826)	(2,981)
Excess tax benefit from equity awards	6,327	3,479
Cash paid for contingent consideration		(3,250)
Other	(150)
Net cash provided by financing activities	261,764	316,024
Effect of exchange rate changes on cash	1,213
Net (decrease) increase in cash and cash equivalents	(59,468)	273,175
Cash and cash equivalents at beginning of the period	94,040	4,569
Cash and cash equivalents at end of the period	34,572	277,744
Effect of acquisitions:
Assets acquired, excluding cash	1,636,164	10,500
Liabilities assumed	(1,009,944)
Issuance of common stock in connection with acquisition	(380,210)	374,336
Deposits paid for acquisitions	40,724
Prior year deposits paid for acquisitions		(500)
Cash paid for acquisitions, net of cash acquired	$ 286,734	$ 10,000

Description of Business and Bas

Description of Business and Basis of Presentation	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Description of Business and Basis of Presentation	1. Description of Business and Basis of Presentation Description of Business Acadia Healthcare Company, Inc. (the “Company”) develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico. At June 30, 2015, the Company operated 223 behavioral healthcare facilities with over 9,000 beds in 37 states, the United Kingdom and Puerto Rico. Basis of Presentation The business of the Company is conducted through limited liability companies, partnerships and C-corporations, each of which is a direct or indirect wholly-owned subsidiary of the Company. The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, all of which are 100% owned. All intercompany accounts and transactions have been eliminated in consolidation. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation of our financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The condensed consolidated balance sheet at December 31, 2014 has been derived from the audited financial statements as of that date. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto for the fiscal year ended December 31, 2014 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2015. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Certain reclassifications have been made to prior years to conform to the current year presentation.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share	2. Earnings Per Share Basic and diluted earnings per share are calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 260, “ Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2015 and 2014 (in thousands except per share amounts): Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Numerator: Basic and diluted earnings per share: Income from continuing operations $ 33,843 $ 22,457 $ 48,435 $ 35,478 Income (loss) from discontinued operations 1 (6 ) 3 31 Net income $ 33,844 $ 22,451 $ 48,438 $ 35,509 Denominator: Weighted average shares outstanding for basic earnings per share 68,296 51,616 65,429 50,872 Effect of dilutive instruments 439 203 353 302 Shares used in computing diluted earnings per common share 68,735 51,819 65,782 51,174 Basic earnings per share: Income from continuing operations $ 0.50 $ 0.43 $ 0.74 $ 0.70 Income (loss) from discontinued operations — — — — Net income $ 0.50 $ 0.43 $ 0.74 $ 0.70 Diluted earnings per share: Income from continuing operations $ 0.49 $ 0.43 $ 0.74 $ 0.69 Income (loss) from discontinued operations — — — — Net income $ 0.49 $ 0.43 $ 0.74 $ 0.69 Approximately 0.3 million and 0.6 million shares of common stock issuable upon exercise of outstanding stock option awards were excluded from the calculation of diluted earnings per share for the three months ended June 30, 2015 and 2014, respectively, because their effect would have been anti-dilutive. Approximately 0.9 million and 0.5 million shares of common stock issuable upon exercise of outstanding stock option awards were excluded from the calculation of diluted earnings per share for the six months ended June 30, 2015 and 2014, respectively, because their effect would have been anti-dilutive.

Acquisitions

Acquisitions	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
Acquisitions	3. Acquisitions UK Acquisitions On June 1, 2015, the Company completed the acquisitions of (i) one facility from Choice for approximately $25.9 million and (ii) 15 facilities from Care UK Limited (“Care UK”) for approximately $88.3 million. The inpatient psychiatric facility acquired from Choice has 42 beds and is located in England. The inpatient psychiatric facilities acquired from Care UK have an aggregate of 299 beds and are located in England. On April 1, 2015, the Company completed the acquisitions of (i) two facilities from Choice Lifestyles (“Choice”) for approximately $37.5 million, (ii) Pastoral Care Group (“Pastoral”) for approximately $34.2 million and (iii) Mildmay Oaks f/k/a Vista Independent Hospital (“Mildmay Oaks”) for approximately $14.9 million. The two inpatient psychiatric facilities acquired from Choice have an aggregate of 48 beds and are located in England. Pastoral operates two inpatient psychiatric facilities with an aggregate of 65 beds located in Wales. Mildmay Oaks is an inpatient psychiatric facility with 67 beds located in England. QAM On March 1, 2015, the Company acquired the stock of Quality Addiction Management, Inc. (“QAM”) for total consideration of approximately $54.6 million. QAM operates seven comprehensive treatment centers located in Wisconsin. CRC On February 11, 2015, the Company completed its acquisition of CRC Health Group, Inc. (“CRC”) for total consideration of approximately $1.3 billion. As consideration for the acquisition, the Company issued 5,975,326 shares of its common stock to certain holders of CRC common stock and repaid CRC’s outstanding indebtedness of $904.5 million. CRC is a leading provider of treatment services related to substance abuse and other addiction and behavioral disorders. At the acquisition date, CRC operated 35 inpatient facilities with over 2,400 beds and 81 comprehensive treatment centers located in 30 states. 2014 Acquisitions On December 1, 2014, the Company acquired the assets of Croxton Warwick Lodge (“Croxton”), an inpatient psychiatric facility with 24 beds located in Melton Mowbray, Leicestershire, England, for cash consideration of $15.6 million. On December 31, 2014, the Company completed the acquisition of Skyway House (“Skyway”), a substance abuse facility with 28 beds located in Chico, California, for cash consideration of $0.3 million. On September 3, 2014, the Company completed the acquisition of McCallum Place (“McCallum”), an eating disorder treatment facility with 85 beds offering residential, partial hospitalization and intensive outpatient treatment programs located in St. Louis, Missouri, and Austin, Texas, for total consideration of $37.4 million. On July 1, 2014, the Company acquired Partnerships in Care for cash consideration of $661.7 million, which was net of cash acquired of $12.0 million and the gain on settlement of foreign currency derivatives of $15.3 million. At the acquisition date, Partnerships in Care was the second largest independent provider of inpatient behavioral healthcare services in the United Kingdom, operating 23 inpatient behavioral healthcare facilities with over 1,200 beds. On January 1, 2014, the Company acquired the assets of Pacific Grove Hospital (“Pacific Grove”), an inpatient psychiatric facility with 68 beds located in Riverside, California, for cash consideration of $10.5 million. Summary of Acquisitions The Company selectively seeks opportunities to expand and diversify its base of operations by acquiring additional facilities. Approximately $175.5 million of the goodwill associated with domestic acquisitions completed in 2015 and 2014 is deductible for federal income tax purposes. The fair values assigned to certain assets and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. Specifically, the Company is further assessing the valuation of certain tax matters as well as certain receivables and assumed liabilities of Choice, Care UK, Pastoral, Mildmay Oaks, QAM, CRC and McCallum, the valuation of real property and intangible assets of Choice, Pastoral, Mildmay Oaks, Care UK, QAM and CRC and the valuation of certain tax matters of Partnerships in Care. The preliminary fair values of assets acquired and liabilities assumed, at the corresponding acquisition dates, during the six months ended June 30, 2015 in connection with the 2015 acquisitions were as follows (in thousands): CRC Other Total Cash $ 19,600 $ 4,468 $ 24,068 Accounts receivable 47,095 6,130 53,225 Prepaid expenses and other current assets 25,522 1,380 26,902 Property and equipment 140,152 138,613 278,765 Goodwill 1,050,620 118,486 1,169,106 Intangible assets 37,000 — 37,000 Deferred tax assets – noncurrent 64,688 — 64,688 Other assets 6,478 — 6,478 Total assets acquired 1,391,155 269,077 1,660,232 Accounts payable 5,301 7,114 12,415 Accrued salaries and benefits 14,860 1,642 16,502 Other accrued expenses 38,703 2,546 41,249 Deferred tax liabilities – noncurrent — 1,052 1,052 Long-term debt 904,467 — 904,467 Other liabilities 34,248 11 34,259 Total liabilities assumed 997,579 12,365 1,009,944 Net assets acquired $ 393,576 $ 256,712 $ 650,288 The preliminary fair values of assets acquired and liabilities assumed, at the corresponding acquisition dates, during the year ended December 31, 2014 in connection with the 2014 acquisitions were as follows (in thousands): Partnerships in Care Other Total Cash $ 11,674 $ — $ 11,674 Accounts receivable 7,684 1,849 9,533 Prepaid expenses and other current assets 8,828 169 8,997 Property and equipment 610,477 27,203 637,680 Goodwill 87,047 32,232 119,279 Intangible assets 651 204 855 Other assets 7,037 3,240 10,277 Total assets acquired 733,398 64,897 798,295 Accounts payable 3,958 93 4,051 Accrued salaries and benefits 10,422 — 10,422 Other accrued expenses 7,166 1,014 8,180 Deferred tax liabilities – noncurrent 15,597 — 15,597 Other liabilities 7,704 — 7,704 Total liabilities assumed 44,847 1,107 45,954 Net assets acquired $ 688,551 $ 63,790 $ 752,341 Other The qualitative factors comprising the goodwill acquired in the Pacific Grove, Partnerships in Care, McCallum, Croxton, Skyway, CRC, QAM, Choice, Pastoral, Mildmay Oaks and Care UK acquisitions (collectively the “2014 and 2015 Acquisitions”) include efficiencies derived through synergies expected by the elimination of certain redundant corporate functions and expenses, the ability to leverage call center referrals to a broader provider base, coordination of services provided across the combined network of facilities, achievement of operating efficiencies by benchmarking performance, and applying best practices throughout the combined companies. Transaction-related expenses comprised the following costs for the three and six months ended June 30, 2015 and 2014 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Advisory and financing commitment fees $ — $ — $ 10,337 $ — Legal, accounting and other costs 5,234 3,016 9,054 4,136 Severance and contract termination costs 1,923 — 6,182 459 $ 7,157 $ 3,016 $ 25,573 $ 4,595 Pro Forma Information The condensed consolidated statements of income for the three and six months ended June 30, 2015 include revenue of $222.1 million and $369.7 million, respectively, and income from continuing operations before income taxes of $37.6 million and $58.1 million, respectively, related to the 2014 and 2015 Acquisitions. The condensed consolidated statements of income for the three and six months ended June 30, 2014 include revenue of $1.6 million and $2.9 million, respectively, and income from continuing operations before income taxes of $0.1 million and loss from continuing operations before income taxes of $0.1 million, respectively, related to acquisitions completed in 2014. The following table provides certain pro forma financial information for the Company as if the 2014 and 2015 Acquisitions occurred as of January 1, 2014 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Revenue $ 461,128 $ 431,663 $ 901,582 $ 841,767 Income from continuing operations, before income taxes $ 51,123 $ 32,289 $ 39,293 $ 31,198

Other Intangible Assets

Other Intangible Assets	6 Months Ended
	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Other Intangible Assets	4. Other Intangible Assets Other identifiable intangible assets and related accumulated amortization consisted of the following as of June 30, 2015 and December 31, 2014 (in thousands): Gross Carrying Amount Accumulated Amortization June 30, December 31, June 30, December 31, Intangible assets subject to amortization: Contract intangible assets $ 2,100 $ 2,100 $ (1,540 ) $ (1,330 ) Non-compete agreements 1,247 1,247 (1,205 ) (1,155 ) 3,347 3,347 (2,745 ) (2,485 ) Intangible assets not subject to amortization: Licenses and accreditations 10,318 9,184 — — Trade names 37,800 3,000 — — Certificates of need 9,794 8,590 — — 57,912 20,774 — — Total $ 61,259 $ 24,121 $ (2,745 ) $ (2,485 ) In connection with the CRC acquisition, the Company acquired license and accreditation intangible assets with a fair value of $1.1 million, trade name intangible assets with a fair value of $34.8 million and certificate of need intangible assets with a fair value of $1.1 million. Amortization expense related to definite-lived intangible assets was $0.1 million for both the three months ended June 30, 2015 and 2014, respectively, and $0.3 million for both the six months ended June 30, 2015 and 2014, respectively. Estimated amortization expense for the years ending December 31, 2015, 2016, 2017, 2018 and 2019 is $0.5 million, $0.4 million, $0, $0 and $0, respectively. The Company’s licenses and accreditations, trade names and certificate of need intangible assets have indefinite lives and are, therefore, not subject to amortization.

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2015
Text Block [Abstract]
Property and Equipment	5. Property and Equipment Property and equipment consists of the following as of June 30, 2015 and December 31, 2014 (in thousands): June 30, 2015 December 31, 2014 Land $ 201,362 $ 132,406 Building and improvements 1,102,767 858,055 Equipment 118,736 73,584 Construction in progress 117,930 66,268 1,540,795 1,130,313 Less accumulated depreciation (85,405 ) (60,613 ) Property and equipment, net $ 1,455,390 $ 1,069,700

Long-Term Debt

Long-Term Debt	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Long-Term Debt	6. Long-Term Debt Long-term debt consisted of the following (in thousands): June 30, 2015 December 31, 2014 Amended and Restated Senior Credit Facility: Senior Secured Term A Loans (net of discount of $1,628 and $1,924, respectively) $ 512,497 $ 525,576 Senior Secured Term B Loans (net of discount of $2,377) 495,123 — Senior Secured Revolving Line of Credit — — 12.875% Senior Notes due 2018 (net of discount of $967 and $1,080, respectively) 96,533 96,420 6.125% Senior Notes due 2021 150,000 150,000 5.125% Senior Notes due 2022 300,000 300,000 5.625% Senior Notes due 2023 375,000 — 9.0% and 9.5% Revenue Bonds (net of premium of $1,429 and $1,649, respectively) 24,054 24,274 1,953,207 1,096,270 Less: current portion (38,652 ) (26,965 ) Long-term debt $ 1,914,555 $ 1,069,305 Amended and Restated Senior Credit Facility The Company entered into a senior secured credit facility (the “Senior Secured Credit Facility”) on April 1, 2011. On December 31, 2012, the Company entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) which amended and restated the Senior Secured Credit Facility (“Amended and Restated Senior Credit Facility”). On February 13, 2014, the Company entered into a Fourth Amendment (the “Fourth Amendment”) to the Amended and Restated Credit Agreement, to increase the size of the Amended and Restated Senior Credit Facility and extend the maturity date thereof, which resulted in the Company having a revolving line of credit of up to $300.0 million and term loans of $300.0 million. The Fourth Amendment also reduced the interest rates applicable to the Amended and Restated Senior Credit Facility and provided increased flexibility to the Company in terms of the financial and other restrictive covenants. The Fourth Amendment also provides for a $150.0 million incremental credit facility, with the potential for unlimited additional incremental amounts, provided the Company meets certain financial ratios, in each case subject to customary conditions precedent to borrowing. On June 16, 2014, the Company entered into a Fifth Amendment (the “Fifth Amendment”) to the Amended and Restated Credit Agreement. The Fifth Amendment specifically permitted the Company’s acquisition of Partnerships in Care, gave the Company the ability to incur a tranche of term loan B debt in the future through its incremental credit facility, and modified certain of the restrictive covenants on miscellaneous investments and incurrence of miscellaneous liens. The restrictive covenants on investments in joint ventures and foreign subsidiaries were also amended such that the Company may now invest, in any given fiscal year, up to five percent (5%) of its total assets in both joint ventures and foreign subsidiaries, respectively; provided that the aggregate amount of investments in both joint ventures and foreign subsidiaries, respectively, may not exceed ten percent (10%) of its total assets over the life of the Amended and Restated Senior Credit Facility; provided further that the aggregate amount of investments made in both joint ventures and foreign subsidiaries collectively pursuant to the foregoing may not exceed fifteen percent (15%) of its total assets. Finally, the Fifth Amendment provided increased flexibility to the Company in terms of its financial covenants. On December 15, 2014, the Company entered into a Sixth Amendment (the “Sixth Amendment”) to our Amended and Restated Credit Agreement. Pursuant to the Sixth Amendment, we incurred $235.0 million of additional term loans. A portion of the additional term loan advance was used to prepay our outstanding revolving loans, and a portion of the additional term loan advance is being held as cash on the consolidated balance sheet. The Sixth Amendment also specifically permitted the acquisition of CRC. In connection with the acquisition of CRC, the Sixth Amendment (i) imposed a temporary reserve on the Company’s revolving credit facility in the amount of $110.0 million in order to preserve such reserved amounts for later borrowings to partially fund the consideration for the acquisition of CRC (subject to limited conditionality provisions) (the reserve is no longer in effect due to the acquisition of CRC), (ii) permitted the incurrence of an additional incremental term loan facility under the Amended and Restated Credit Agreement partially to fund the consideration for the acquisition of CRC (subject to limited conditionality provisions) and (iii) permitted the issuance of additional senior unsecured indebtedness or senior unsecured bridge indebtedness partially to fund the consideration for the acquisition of CRC. On February 6, 2015, the Company entered into a Seventh Amendment (the “Seventh Amendment”) to our Amended and Restated Credit Agreement. The Seventh Amendment added Citibank, N.A. as an “L/C Issuer” under the Amended and Restated Credit Agreement in order to permit the rollover of CRC’s existing letters of credit into the Amended and Restated Credit Agreement and increased both the Company’s Letter of Credit Sublimit and Swing Line Sublimit to $20.0 million. On February 11, 2015, the Company entered into a First Incremental Facility Amendment (the “First Incremental Amendment”) to our Amended and Restated Credit Agreement. The First Incremental Amendment activated a new $500.0 million incremental Term Loan B facility (the “TLB Facility”) that was added to our Amended and Restated Senior Credit Facility, subject to limited conditionality provisions. Borrowings under the TLB Facility were used to fund a portion of the purchase price for the acquisition of CRC. On April 22, 2015, the Company entered into an Eighth Amendment (the “Eighth Amendment”) to our Amended and Restated Credit Agreement. The Eighth Amendment changed the definition of “Change of Control” in part to remove a provision whose purpose was, when calculating whether a majority of incumbent directors have approved new directors, that any incumbent director that became a director as a result of a threatened or actual proxy contest was not counted in such calculation. The Company had $291.1 million of availability under the revolving line of credit as of June 30, 2015. Borrowings under the revolving line of credit are subject to customary conditions precedent to borrowing. The Amended and Restated Credit Agreement requires quarterly term loan principal repayments of our outstanding term loan A loans (“TLA Facility”) of $6.7 million for June 30, 2015 to December 31, 2015, $10.0 million for March 31, 2016 to December 31, 2016, $13.4 million for March 31, 2017 to December 31, 2017, and $16.7 million for March 31, 2018 to December 31, 2018, with the remaining principal balance of the TLA Facility due on the maturity date of February 13, 2019. On December 15, 2014, prior to the execution of the Sixth Amendment, the Company prepaid the December 31, 2014 quarterly term loan principal payment of $1.9 million. The Company is required to repay the TLB Facility in equal quarterly installments of $1.3 million on the last business day of each March, June, September and December, with the outstanding principal balance of the TLB Facility due on February 11, 2022. Borrowings under the Amended and Restated Senior Credit Facility are guaranteed by each of the Company’s wholly-owned domestic subsidiaries (other than certain excluded subsidiaries) and are secured by a lien on substantially all of the assets of the Company and such subsidiaries. Borrowings with respect to the TLA Facility and the Company’s revolving credit facility (collectively, “Pro Rata Facilities”) under the Amended and Restated Credit Agreement bear interest at a rate tied to Acadia’s Consolidated Leverage Ratio (defined as consolidated funded debt net of up to $40.0 million of unrestricted and unencumbered cash to consolidated EBITDA, in each case as defined in the Amended and Restated Credit Agreement). The Applicable Rate (as defined in the Amended and Restated Credit Agreement) for the Pro Rata Facilities was 3.25% for Eurodollar Rate Loans (as defined in the Amended and Restated Credit Agreement) and 2.25% for Base Rate Loans (as defined in the Amended and Restated Credit Agreement) at June 30, 2015. Eurodollar Rate Loans with respect to the Pro Rata Facilities bear interest at the Applicable Rate plus the Eurodollar Rate (as defined in the Amended and Restated Credit Agreement) (based upon the LIBOR Rate (as defined in the Amended and Restated Credit Agreement) prior to commencement of the interest rate period). Base Rate Loans with respect to the Pro Rata Facilities bear interest at the Applicable Rate plus the highest of (i) the federal funds rate plus 0.50%, (ii) the prime rate and (iii) the Eurodollar Rate plus 1.0%. As of June 30, 2015, the Pro Rata Facilities bore interest at a rate of LIBOR plus 3.25%. In addition, we are required to pay a commitment fee on undrawn amounts under the revolving line of credit. We paid a commitment fee of 0.50% for undrawn amounts for the period from January 1, 2013 through February 12, 2014 and 0.40% for undrawn amounts for the period from February 13, 2014 through June 30, 2015. Borrowings under the Pro Rata Facilities mature on February 13, 2019. The Amended and Restated Credit Agreement requires the Company and its subsidiaries to comply with customary affirmative, negative and financial covenants, including a fixed charge coverage ratio, consolidated leverage ratio and senior secured leverage ratio. The Company may be required to pay all of its indebtedness immediately if it defaults on any of the numerous financial or other restrictive covenants contained in any of its material debt agreements. As of June 30, 2015, the Company was in compliance with such covenants. 12.875% Senior Notes due 2018 On November 1, 2011, the Company issued $150.0 million of 12.875% Senior Notes due 2018 (the “12.875% Senior Notes”) at 98.323% of the aggregate principal amount of $150.0 million, a discount of $2.5 million. The notes bear interest at a rate of 12.875% per annum. The Company pays interest on the notes semi-annually, in arrears, on November 1 and May 1 of each year. The indenture governing the 12.875% Senior Notes contains covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to: (i) pay dividends, redeem stock or make other distributions or investments; (ii) incur additional debt or issue certain preferred stock; (iii) transfer or sell assets; (iv) engage in certain transactions with affiliates; (v) create restrictions on dividends or other payments by the restricted subsidiaries; (vi) merge, consolidate or sell substantially all of the Company’s assets; and (vii) create liens on assets. The 12.875% Senior Notes issued by the Company are guaranteed by each of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. The guarantees are full and unconditional and joint and several. On March 12, 2013, the Company redeemed $52.5 million in principal amount of the 12.875% Senior Notes using a portion of the net proceeds of its December 2012 equity offering pursuant to the provision in the indenture permitting an optional redemption with equity proceeds of up to 35% of the principal amount of 12.875% Senior Notes. The 12.875% Senior Notes were redeemed at a redemption price of 112.875% of the principal amount thereof plus accrued and unpaid interest to, but not including, the redemption date in accordance with the provisions of the indenture governing the 12.875% Senior Notes. As part of the redemption of 35% of the 12.875% Senior Notes, the Company recorded a debt extinguishment charge of $9.4 million, including the premium and write-off of deferred financing costs, which was recorded in debt extinguishment costs in the consolidated statements of income. 6.125% Senior Notes due 2021 On March 12, 2013, the Company issued $150.0 million of 6.125% Senior Notes due 2021 (the “6.125% Senior Notes”). The 6.125% Senior Notes mature on March 15, 2021 and bear interest at a rate of 6.125% per annum, payable semi-annually in arrears on March 15 and September 15 of each year. The indenture governing the 6.125% Senior Notes contains covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to: (i) pay dividends, redeem stock or make other distributions or investments; (ii) incur additional debt or issue certain preferred stock; (iii) transfer or sell assets; (iv) engage in certain transactions with affiliates; (v) create restrictions on dividends or other payments by the restricted subsidiaries; (vi) merge, consolidate or sell substantially all of the Company’s assets; and (vii) create liens on assets. The 6.125% Senior Notes issued by the Company are guaranteed by each of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. The guarantees are full and unconditional and joint and several. The Company may redeem the 6.125% Senior Notes at its option, in whole or part, at any time prior to March 15, 2016, at a price equal to 100% of the principal amount of the 6.125% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. The Company may redeem the 6.125% Senior Notes, in whole or in part, on or after March 15, 2016, at the redemption prices set forth in the indenture governing the 6.125% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before March 15, 2016, the Company may elect to redeem up to 35% of the aggregate principal amount of the 6.125% Senior Notes at a redemption price equal to 106.125% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings. 5.125% Senior Notes due 2022 On July 1, 2014, the Company issued $300.0 million of 5.125% Senior Notes (the “5.125% Senior Notes”). The 5.125% Senior Notes mature on July 1, 2022 and bear interest at a rate of 5.125% per annum, payable semi-annually in arrears on January 1 and July 1 of each year, beginning on January 1, 2015. The indenture governing the 5.125% Senior Notes contains covenants that limit, among other things, the Company’s ability and the ability of its restricted subsidiaries to: (i) pay dividends, redeem stock or make other distributions or investments; (ii) incur additional debt or issue certain preferred stock; (iii) transfer or sell assets; (iv) engage in certain transactions with affiliates; (v) create restrictions on dividends or other payments by the restricted subsidiaries; (vi) merge, consolidate or sell substantially all of the Company’s assets and (vii) create liens on assets. The 5.125% Senior Notes issued by the Company are guaranteed by each of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. The guarantees are full and unconditional and joint and several. The Company may redeem the 5.125% Senior Notes at its option, in whole or part, at any time prior to July 1, 2017, at a price equal to 100% of the principal amount of the 5.125% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. The Company may redeem the 5.125% Senior Notes, in whole or in part, on or after July 1, 2017, at the redemption prices set forth in the indenture governing the 5.125% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before July 1, 2017, the Company may elect to redeem up to 35% of the aggregate principal amount of the 5.125% Senior Notes at a redemption price equal to 105.125% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings. 5.625% Senior Notes due 2023 On February 11, 2015, the Company issued $375.0 million of 5.625% Senior Notes due 2023 (the “5.625% Senior Notes”). The 5.625% Senior Notes mature on February 15, 2023 and bear interest at a rate of 5.625% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2015. The indenture governing the 5.625% Senior Notes contains covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to: (i) pay dividends, redeem stock or make other distributions or investments; (ii) incur additional debt or issue certain preferred stock; (iii) transfer or sell assets; (iv) engage in certain transactions with affiliates; (v) create restrictions on dividends or other payments by the restricted subsidiaries; (vi) merge, consolidate or sell substantially all of the Company’s assets and (vii) create liens on assets. The 5.625% Senior Notes issued by the Company are guaranteed by each of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. The guarantees are full and unconditional and joint and several. The Company may redeem the 5.625% Senior Notes at its option, in whole or part, at any time prior to February 15, 2018, at a price equal to 100% of the principal amount of the 5.625% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. We may redeem the 5.625% Senior Notes, in whole or in part, on or after February 15, 2018, at the redemption prices set forth in the indenture governing the 5.625% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before February 15, 2018, the Company may elect to redeem up to 35% of the aggregate principal amount of the 5.625% Senior Notes at a redemption price equal to 105.625% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings. 9.0% and 9.5% Revenue Bonds On November 11, 2012, in connection with the acquisition of Park Royal, the Company assumed debt of $23.0 million. The fair market value of the debt assumed was $25.6 million and resulted in a debt premium balance being recorded as of the acquisition date. The debt consisted of $7.5 million and $15.5 million of Lee County (Florida) Industrial Development Authority Healthcare Facilities Revenue Bonds, Series 2010 with stated interest rates of 9.0% and 9.5% (“9.0% and 9.5% Revenue Bonds”), respectively. The 9.0% bonds in the amount of $7.5 million have a maturity date of December 1, 2030 and require yearly principal payments beginning in 2013. The 9.5% bonds in the amount of $15.5 million have a maturity date of December 1, 2040 and require yearly principal payments beginning in 2031. The principal payments establish a bond sinking fund to be held with the trustee and shall be sufficient to redeem the principal amounts of the 9.0% and 9.5% Revenue Bonds on their respective maturity dates. As of June 30, 2015 and December 31, 2014, $2.3 million was recorded within other assets on the balance sheet related to the debt service reserve fund requirements. The yearly principal payments, which establish a bond sinking fund, will increase the debt service reserve fund requirements. The bond premium amount of $2.6 million is amortized as a reduction of interest expense over the life of the revenue bonds using the effective interest method.

Equity Offerings

Equity Offerings	6 Months Ended
	Jun. 30, 2015
Equity [Abstract]
Equity Offerings	7. Equity Offerings On June 17, 2014, the Company completed the offering of 8,881,794 shares of common stock (including shares sold pursuant to the exercise of the over-allotment option that the Company granted to the underwriters as part of the offering) at a price of $44.00 per share. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discount of $15.6 million and additional offering-related costs of $0.8 million, were $374.4 million. The Company used the net offering proceeds to fund a portion of the consideration for the acquisition of Partnerships in Care. On February 11, 2015, the Company completed its acquisition of CRC for total consideration of approximately $1.3 billion. As consideration for the acquisition, the Company issued 5,975,326 shares of its common stock to certain holders of CRC common stock and repaid CRC’s outstanding indebtedness. On May 11, 2015, the Company completed the offering of 5,175,000 shares of common stock (including shares sold pursuant to the exercise of the over-allotment option that the Company granted to the underwriters as part of the offering) at a price of $66.50 per share. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discount of $12.0 million and additional offering-related costs of $0.6 million, were $331.5 million. The Company used the net offering proceeds to repay outstanding indebtedness and fund acquisitions.

Equity-Based Compensation

Equity-Based Compensation	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Equity-Based Compensation	8. Equity-Based Compensation Equity Incentive Plans The Company issues stock-based awards, including stock options, restricted stock and restricted stock units, to certain officers, employees and non-employee directors under the Acadia Healthcare Company, Inc. Incentive Compensation Plan (the “Equity Incentive Plan”). As of June 30, 2015, a maximum of 4,700,000 shares of the Company’s common stock were authorized for issuance as stock options, restricted stock and restricted stock units or other share-based compensation under the Equity Incentive Plan, of which 1,257,326 were available for future grant. Stock options may be granted for terms of up to ten years. The Company recognizes expense on all share-based awards on a straight-line basis over the requisite service period of the entire award. Grants to employees generally vest in annual increments of 25% each year, commencing one year after the date of grant. The exercise prices of stock options are equal to the most recent closing price of the Company’s common stock on the date of grant. The Company recognized $5.4 million and $2.4 million in equity-based compensation expense for the three months ended June 30, 2015 and 2014, respectively, and $9.2 million and $4.2 million for the six months ended June 30, 2015 and 2014, respectively. As of June 30, 2015, there was $57.7 million of unrecognized compensation expense related to unvested options, restricted stock and restricted stock units, which is expected to be recognized over the remaining weighted average vesting period of 1.6 years. As of June 30, 2015, there were no warrants outstanding. The Company recognized a deferred income tax benefit of $2.2 million and $1.0 million for the three months ended June 30, 2015 and 2014, respectively, related to equity-based compensation expense. The Company recognized a deferred income tax benefit of $3.8 million and $1.7 million for the six months ended June 30, 2015 and 2014, respectively, related to equity-based compensation expense. The actual tax benefit realized from stock options exercised during the three months ended June 30, 2015 and 2014 was $2.0 million and $0.8 million, respectively. The actual tax benefit realized from stock options exercised during the six months ended June 30, 2015 and 2014 was $6.3 million and $3.5 million, respectively. Stock option activity during 2014 and 2015 was as follows (aggregate intrinsic value in thousands): Number Weighted Weighted Aggregate Options outstanding at January 1, 2014 798,809 $ 21.93 8.20 $ 10,700 Options granted 226,663 49.80 9.25 209 Options exercised (210,199 ) 14.93 N/A 4,994 Options cancelled (77,851 ) 27.85 N/A N/A Options outstanding at December 31, 2014 737,422 32.19 8.09 14,512 Options granted 190,900 62.37 9.68 1,148 Options exercised (49,045 ) 23.66 N/A 5,197 Options cancelled (88,264 ) 47.86 N/A N/A Options outstanding at June 30, 2015 791,013 $ 40.28 8.09 $ 23,104 Options exercisable at December 31, 2014 91,947 $ 28.87 6.30 $ 3,326 Options exercisable at June 30, 2015 153,900 $ 34.84 6.60 $ 6,941 Restricted stock activity during 2014 and 2015 was as follows: Number of Weighted Grant-Date Unvested at January 1, 2014 461,697 $ 24.96 Granted 468,484 48.99 Cancelled (75,369 ) 36.36 Vested (132,784 ) 22.81 Unvested at December 31, 2014 722,028 $ 39.77 Granted 480,152 62.08 Cancelled (55,674 ) 49.59 Vested (107,263 ) 32.47 Unvested at June 30, 2015 1,039,243 $ 51.03 Restricted stock unit activity during 2014 and 2015 was as follows: Number of Weighted Grant-Date Unvested at January 1, 2014 95,751 $ 23.05 Granted 108,449 50.75 Cancelled — — Vested (79,087 ) 21.81 Unvested at December 31, 2014 125,113 $ 38.73 Granted 217,994 61.77 Cancelled — — Vested (125,023 ) 32.38 Unvested at June 30, 2015 218,084 $ 56.97 The grant-date fair value of the Company’s stock options is estimated using the Black-Scholes option pricing model. The following table summarizes the grant-date fair value of options and the assumptions used to develop the fair value estimates for options granted during the six months ended June 30, 2015 and year ended December 31, 2014: June 30, 2015 December 31, 2014 Weighted average grant-date fair value of options $ 24.30 $ 17.14 Risk-free interest rate 1.9 % 1.7 % Expected volatility 33 % 36 % Expected life (in years) 5.5 5.5 The Company’s estimate of expected volatility for stock options is based upon the volatility of guideline companies given the lack of sufficient historical trading experience of the Company’s common stock. The risk-free interest rate is the approximate yield on United States Treasury Strips having a life equal to the expected option life on the date of grant. The expected life is an estimate of the number of years an option will be held before it is exercised.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2015
Income Tax Disclosure [Abstract]
Income Taxes	9. Income Taxes The provision for income taxes for continuing operations for the three months ended June 30, 2015 and 2014 reflects effective tax rates of 31.4% and 39.9%, respectively. The provision for income taxes for continuing operations for the six months ended June 30, 2015 and 2014 reflects effective tax rates of 31.4% and 39.0%, respectively. The decrease in the tax rate for the three and six months ended June 30, 2015 was primarily attributable to the acquisition of Partnerships in Care, which is located in a lower taxing jurisdiction and for which earnings are permanently reinvested.

Derivatives

Derivatives	6 Months Ended
	Jun. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	10. Derivatives The Company entered into foreign currency forward contracts during the three and six months ended June 30, 2015 and 2014 in connection with acquisitions in the United Kingdom. The foreign currency forward contracts limited the economic risk of changes in the foreign exchange rate between US Dollars (“USD”) and British Pounds (“GBP”) associated with the payment of the purchase price in GBP in April 2015 and July 2014. These foreign currency forward contracts did not meet the hedge accounting criteria under Accounting Standards Codification 815, Derivatives and Hedging

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value Measurements	11. Fair Value Measurements The carrying amounts reported for cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities approximate fair value because of the short-term maturity of these instruments. The carrying amounts and fair values of the Company’s Amended and Restated Senior Credit Facility, 12.875% Senior Notes, 6.125% Senior Notes, 5.125% Senior Notes, 5.625% Senior Notes, 9.0% and 9.5% Revenue Bonds and contingent consideration liabilities as of June 30, 2015 and December 31, 2014 were as follows (in thousands): Carrying Amount Fair Value June 30, December 31, June 30, December 31, Amended and Restated Senior Credit Facility $ 1,007,620 $ 525,576 $ 1,007,620 $ 525,576 12.875% Senior Notes due 2018 $ 96,533 $ 96,420 $ 106,519 $ 109,688 6.125% Senior Notes due 2021 $ 150,000 $ 150,000 $ 154,500 $ 153,000 5.125% Senior Notes due 2022 $ 300,000 $ 300,000 $ 297,750 $ 295,500 5.625% Senior Notes due 2023 $ 375,000 — $ 379,688 — 9.0% and 9.5% Revenue Bonds $ 24,054 $ 24,274 $ 24,054 $ 24,274 Contingent consideration liabilities $ 3,000 $ 3,000 $ 3,000 $ 3,000 The Company’s Amended and Restated Senior Credit Facility, 12.875% Senior Notes, 6.125% Senior Notes, 5.125% Senior Notes, 5.625% Senior Notes and 9.0% and 9.5% Revenue Bonds were categorized as Level 2 in the GAAP fair value hierarchy. Fair values were based on trading activity among the Company’s lenders and the average bid and ask price as determined using published rates. The fair value of the contingent consideration liabilities were categorized as Level 3 in the GAAP fair value hierarchy. The contingent consideration liabilities were valued using a probability-weighted discounted cash flow method. This analysis reflected the contractual terms of the purchase agreements and utilized assumptions with regard to future earnings, probabilities of achieving such future earnings and a discount rate. Significant increases with respect to assumptions as to future earnings and probabilities of achieving such future earnings would result in higher fair value measurement while an increase in the discount rate would result in a lower fair value measurement. During the six months ended June 30, 2014, the Company changed its projections of the timing of future payments of the contingent consideration liability related to the acquisition of The Pavilion at Healthpark LLC (“Park Royal”). This change resulted in a $0.5 million increase in the fair value of the contingent consideration liability, which was recorded in transaction-related expenses in the consolidated statements of income. During the year ended December 31, 2014, the Company paid $5.0 million of the estimated $7.0 million Park Royal contingent consideration liability as a result of the facility achieving certain earnings targets. In addition to the Park Royal contingent consideration liability, the Company may make an earn-out payment of up to $6.0 million to the former owners of McCallum, contingent upon achievement by McCallum of certain operating performance targets for the one-year period ending December 31, 2015.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	12. Commitments and Contingencies The Company is, from time to time, subject to various claims and legal actions that arise in the ordinary course of the Company’s business, including claims for damages for personal injuries, medical malpractice, breach of contract, tort and employment related claims. In these actions, plaintiffs request a variety of damages, including, in some instances, punitive and other types of damages that may not be covered by insurance. In the opinion of management, the Company is not currently a party to any proceeding that would individually or in the aggregate have a material adverse effect on the Company’s business, financial condition or results of operations.

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2015
Segment Reporting [Abstract]
Segment Information	13. Segment Information The Company operates in one line of business, which is operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As management reviews the operating results of its facilities in the United States (the “U.S. Facilities”) and its facilities in the United Kingdom (the “U.K. Facilities”) separately to assess performance and make decisions, the Company’s operating segments include its U.S. Facilities and U.K. Facilities. At June 30, 2015, the U.S. Facilities included 178 behavioral healthcare facilities with approximately 7,200 beds in 37 states and Puerto Rico, and the U.K. Facilities included 45 behavioral healthcare facilities with approximately 1,800 beds in the United Kingdom. The following tables set forth the financial information by operating segment, including a reconciliation of Segment EBITDA to income from continuing operations before income taxes (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Revenue: U.S. Facilities $ 366,886 $ 212,834 $ 657,393 $ 413,398 U.K. Facilities 84,927 — 158,242 — Corporate and Other 1,847 969 3,808 1,823 $ 453,660 $ 213,803 $ 819,443 $ 415,221 Segment EBITDA (1): U.S. Facilities $ 102,342 $ 53,031 $ 178,706 $ 100,563 U.K. Facilities 20,371 — 39,182 — Corporate and Other (16,910 ) (8,317 ) (33,373 ) (16,567 ) $ 105,803 $ 44,714 $ 184,515 $ 83,996 Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Segment EBITDA (1) $ 105,803 $ 44,714 $ 184,515 $ 83,996 Plus (less): Equity-based compensation expense (5,355 ) (2,406 ) (9,249 ) (4,170 ) (Loss) gain on foreign currency derivatives (961 ) 13,735 (908 ) 13,735 Transaction-related expenses (7,157 ) (3,016 ) (25,573 ) (4,595 ) Interest expense, net (28,049 ) (9,730 ) (50,195 ) (19,437 ) Depreciation and amortization (14,926 ) (5,935 ) (28,030 ) (11,371 ) Income from continuing operations before income taxes $ 49,355 $ 37,362 $ 70,560 $ 58,158 U.S. Facilities U.K. Facilities Corporate Consolidated Goodwill: Balance at January 1, 2015 $ 693,945 $ 109,041 $ — $ 802,986 Increase from 2015 acquisitions 1,103,813 65,293 — 1,169,106 Foreign currency translation — 6,972 — 6,972 Purchase price allocation and other 281 (33,317 ) — (33,036 ) Balance at June 30, 2015 $ 1,798,039 $ 147,989 $ — $ 1,946,028 June 30, 2015 December 31, 2014 Assets (2): U.S. Facilities $ 2,729,896 $ 1,327,563 U.K. Facilities 944,033 726,693 Corporate and Other 252,456 169,334 $ 3,926,385 $ 2,223,590 (1) Segment EBITDA is defined as income from continuing operations before provision for income taxes, equity-based compensation expense, gain/loss on foreign currency derivatives, transaction-related expenses, interest expense and depreciation and amortization. The Company uses Segment EBITDA as an analytical indicator to measure the performance of the Company’s segments and to develop strategic objectives and operating plans for those segments. Segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from Segment EBITDA are significant components in understanding and assessing financial performance. Because Segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, Segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. (2) Assets include property and equipment for the U.S. Facilities of $671.2 million, U.K. Facilities of $754.2 million and corporate and other of $30.0 million at June 30, 2015. Assets include property and equipment for the U.S. Facilities of $478.1 million, U.K. Facilities of $578.6 million and corporate and other of $13.0 million at December 31, 2014.

Recently Issued Accounting Stan

Recently Issued Accounting Standards	6 Months Ended
	Jun. 30, 2015
Accounting Changes and Error Corrections [Abstract]
Recently Issued Accounting Standards	14. Recently Issued Accounting Standards In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2015-03, “Interest-Imputation of Interest (Subtopic 835-30)” In May 2014, the FASB and the International Accounting Standards Board issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2015
Subsequent Events [Abstract]
Subsequent Events	15. Subsequent Events On July 1, 2015, the Company completed the acquisition of (i) the assets of Belmont Behavioral Health, an inpatient psychiatric facility with 147 beds located in Philadelphia, Pennsylvania for cash consideration of approximately $40.0 million which consists of $35.0 million base purchase price and an estimated working capital settlement of $5.0 million, and (ii) The Manor Clinic, a substance abuse facility with 15 beds located in England, for cash consideration of approximately $5.9 million.

Financial Information for the C

Financial Information for the Company and Its Subsidiaries	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Financial Information for the Company and Its Subsidiaries	16. Financial Information for the Company and Its Subsidiaries The Company conducts substantially all of its business through its subsidiaries. The 12.875% Senior Notes, 6.125% Senior Notes, 5.125% Senior Notes and 5.625% Senior Notes are jointly and severally guaranteed on an unsecured senior basis by all of the Company’s subsidiaries that guarantee the Company’s obligations under the Amended and Restated Senior Credit Facility. Presented below is condensed consolidating financial information for the Company and its subsidiaries as of June 30, 2015 and December 31, 2014, and for the three and six months ended June 30, 2015 and 2014. The information segregates the parent company (Acadia Healthcare Company, Inc.), the combined wholly-owned subsidiary guarantors, the combined non-guarantor subsidiaries and eliminations. Acadia Healthcare Company, Inc. Condensed Consolidating Balance Sheets June 30, 2015 (In thousands) Parent Combined Combined Consolidating Total Current assets: Cash and cash equivalents $ — $ 17,179 $ 17,393 $ — $ 34,572 Accounts receivable, net — 160,179 22,136 — 182,315 Deferred tax assets — 36,502 2,191 — 38,693 Other current assets — 62,295 8,030 — 70,325 Total current assets — 276,155 49,750 — 325,905 Property and equipment, net — 656,262 799,128 — 1,455,390 Goodwill — 1,700,705 245,323 — 1,946,028 Intangible assets, net — 55,928 2,586 — 58,514 Deferred tax assets – noncurrent 5,361 16,239 12,366 — 33,966 Investment in subsidiaries 1,332,308 — — (1,332,308 ) — Other assets 389,676 65,957 2,322 (351,373 ) 106,582 Total assets $ 1,727,345 $ 2,771,246 $ 1,111,475 $ (1,683,681 ) $ 3,926,385 Current liabilities: Current portion of long-term debt $ 38,437 $ — $ 215 $ — $ 38,652 Accounts payable — 44,985 13,729 — 58,714 Accrued salaries and benefits — 65,040 12,505 — 77,545 Other accrued liabilities 22,604 27,543 18,050 — 68,197 Total current liabilities 61,041 137,568 44,499 — 243,108 Long-term debt — 1,890,716 375,212 (351,373 ) 1,914,555 Deferred tax liabilities – noncurrent — — 20,200 — 20,200 Other liabilities — 72,329 9,889 — 82,218 Total liabilities 61,041 2,100,613 449,800 (351,373 ) 2,260,081 Total equity 1,666,304 670,633 661,675 (1,332,308 ) 1,666,304 Total liabilities and equity $ 1,727,345 $ 2,771,246 $ 1,111,475 $ (1,683,681 ) $ 3,926,385 Acadia Healthcare Company, Inc. Condensed Consolidating Balance Sheets December 31, 2014 (In thousands) Parent Combined Combined Consolidating Total Current assets: Cash and cash equivalents $ — $ 76,685 $ 17,355 $ — $ 94,040 Accounts receivable, net — 100,797 17,581 — 118,378 Deferred tax assets — 18,395 1,760 — 20,155 Other current assets — 36,049 5,521 — 41,570 Total current assets — 231,926 42,217 — 274,143 Property and equipment, net — 451,943 617,757 — 1,069,700 Goodwill — 596,611 206,375 — 802,986 Intangible assets, net — 19,057 2,579 — 21,636 Deferred tax assets – noncurrent 4,563 — 14,244 (5,666 ) 13,141 Investment in subsidiaries 1,759,337 — — (1,759,337 ) — Other assets 202,708 18,727 2,323 (181,774 ) 41,984 Total assets $ 1,966,608 $ 1,318,264 $ 885,495 $ (1,946,777 ) $ 2,223,590 Current liabilities: Current portion of long-term debt $ 26,750 $ — $ 215 $ — $ 26,965 Accounts payable — 39,486 9,210 — 48,696 Accrued salaries and benefits — 47,597 11,720 — 59,317 Other accrued liabilities 13,647 7,688 9,621 — 30,956 Total current liabilities 40,397 94,771 30,766 — 165,934 Long-term debt 1,045,246 — 205,833 (181,774 ) 1,069,305 Deferred tax liabilities – noncurrent — 21,027 48,519 (5,666 ) 63,880 Other liabilities — 33,321 10,185 — 43,506 Total liabilities 1,085,643 149,119 295,303 (187,440 ) 1,342,625 Total equity 880,965 1,169,145 590,192 (1,759,337 ) 880,965 Total liabilities and equity $ 1,966,608 $ 1,318,264 $ 885,495 $ (1,946,777 ) $ 2,223,590 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Comprehensive Income Three Months Ended June 30, 2015 (In thousands) Parent Combined Combined Consolidating Total Revenue before provision for doubtful accounts $ — $ 363,851 $ 97,947 $ — $ 461,798 Provision for doubtful accounts — (7,566 ) (572 ) — (8,138 ) Revenue — 356,285 97,375 — 453,660 Salaries, wages and benefits 5,355 183,490 54,457 — 243,302 Professional fees — 22,579 7,450 — 30,029 Supplies — 16,929 3,613 — 20,542 Rents and leases — 7,402 809 — 8,211 Other operating expenses — 43,145 7,983 — 51,128 Depreciation and amortization — 10,551 4,375 — 14,926 Interest expense, net 18,106 5,882 4,061 — 28,049 Loss on foreign currency derivatives 961 — — — 961 Transaction-related expenses — 2,946 4,211 — 7,157 Total expenses 24,422 292,924 86,959 — 404,305 (Loss) income from continuing operations before income taxes (24,422 ) 63,361 10,416 — 49,355 Equity in earnings of subsidiaries 50,281 — — (50,281 ) — (Benefit from) provision for income taxes (7,985 ) 20,734 2,763 — 15,512 Income (loss) from continuing operations 33,844 42,627 7,653 (50,281 ) 33,843 Income from discontinued operations, net of income taxes — 1 — — 1 Net income (loss) $ 33,844 $ 42,628 $ 7,653 $ (50,281 ) $ 33,844 Other comprehensive income: Foreign currency translation gain — — 46,173 — 46,173 Other comprehensive income — — 46,173 — 46,173 Comprehensive income (loss) $ 33,844 $ 42,628 $ 53,826 $ (50,281 ) $ 80,017 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Comprehensive Income Three Months Ended June 30, 2014 (In thousands) Parent Combined Combined Consolidating Total Revenue before provision for doubtful accounts $ — $ 207,143 $ 13,521 $ — $ 220,664 Provision for doubtful accounts — (5,954 ) (907 ) — (6,861 ) Revenue — 201,189 12,614 — 213,803 Salaries, wages and benefits 2,406 114,976 5,091 — 122,473 Professional fees — 9,691 1,200 — 10,891 Supplies — 9,967 629 — 10,596 Rents and leases — 2,613 276 — 2,889 Other operating expenses — 22,522 2,124 — 24,646 Depreciation and amortization — 5,581 354 — 5,935 Interest expense, net 9,202 — 528 — 9,730 Loss (gain) on foreign currency derivatives (13,735 ) — — — (13,735 ) Transaction-related expenses — 3,016 — — 3,016 Total expenses (2,127 ) 168,366 10,202 — 176,441 Income from continuing operations before income taxes 2,127 32,823 2,412 — 37,362 Equity in earnings of subsidiaries 20,972 — — (20,972 ) — Provision for income taxes 648 13,315 942 — 14,905 Income (loss) from continuing operations 22,451 19,508 1,470 (20,972 ) 22,457 Loss from discontinued operations, net of income taxes — (6 ) — — (6 ) Net income (loss) $ 22,451 $ 19,502 $ 1,470 $ (20,972 ) $ 22,451 Comprehensive income (loss) $ 22,451 $ 19,502 $ 1,470 $ (20,972 ) $ 22,451 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Comprehensive Income Six Months Ended June 30, 2015 (In thousands) Parent Combined Combined Consolidating Total Revenue before provision for doubtful accounts $ — $ 651,616 $ 184,340 $ — $ 835,956 Provision for doubtful accounts — (14,985 ) (1,528 ) — (16,513 ) Revenue — 636,631 182,812 — 819,443 Salaries, wages and benefits 9,249 339,189 100,735 — 449,173 Professional fees — 39,064 13,392 — 52,456 Supplies — 29,938 6,858 — 36,796 Rents and leases — 12,519 1,578 — 14,097 Other operating expenses — 75,392 16,263 — 91,655 Depreciation and amortization — 19,262 8,768 — 28,030 Interest expense, net 31,054 11,603 7,538 — 50,195 Loss on foreign currency derivatives 908 — — — 908 Transaction-related expenses — 21,362 4,211 — 25,573 Total expenses 41,211 548,329 159,343 — 748,883 (Loss) income from continuing operations before income taxes (41,211 ) 88,302 23,469 — 70,560 Equity in earnings of subsidiaries 76,268 — — (76,268 ) — (Benefit from) provision for income taxes (13,381 ) 29,251 6,255 — 22,125 Income (loss) from continuing operations 48,438 59,051 17,214 (76,268 ) 48,435 Income from discontinued operations, net of income taxes — 3 — — 3 Net income (loss) $ 48,438 $ 59,054 $ 17,214 $ (76,268 ) $ 48,438 Other comprehensive income: Foreign currency translation gain — — 16,784 — 16,784 Other comprehensive income — — 16,784 — 16,784 Comprehensive income (loss) $ 48,438 $ 59,054 $ 33,998 $ (76,268 ) $ 65,222 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Comprehensive Income Six Months Ended June 30, 2014 (In thousands) Parent Combined Combined Consolidating Total Revenue before provision for doubtful accounts $ — $ 400,425 $ 26,358 $ — $ 426,783 Provision for doubtful accounts — (10,464 ) (1,098 ) — (11,562 ) Revenue — 389,961 25,260 — 415,221 Salaries, wages and benefits 4,170 225,629 10,249 — 240,048 Professional fees — 18,944 2,329 — 21,273 Supplies — 19,353 1,307 — 20,660 Rents and leases — 5,108 550 — 5,658 Other operating expenses — 43,600 4,156 — 47,756 Depreciation and amortization — 10,666 705 — 11,371 Interest expense, net 18,313 — 1,124 — 19,437 Loss (gain) on foreign currency derivatives (13,735 ) — — — (13,735 ) Transaction-related expenses — 4,595 — — 4,595 Total expenses 8,748 327,895 20,420 — 357,063 (Loss) income from continuing operations before income taxes (8,748 ) 62,066 4,840 — 58,158 Equity in earnings of subsidiaries 40,839 — — (40,839 ) — (Benefit from) provision for income taxes (3,418 ) 24,249 1,849 — 22,680 Income (loss) from continuing operations 35,509 37,817 2,991 (40,839 ) 35,478 Income from discontinued operations, net of income taxes — 31 — — 31 Net income (loss) $ 35,509 $ 37,848 $ 2,991 $ (40,839 ) $ 35,509 Comprehensive income (loss) $ 35,509 $ 37,848 $ 2,991 $ (40,839 ) $ 35,509 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Cash Flows Six Months Ended June 30, 2015 (In thousands) Parent Combined Combined Consolidating Total Operating activities: Net income (loss) $ 48,438 $ 59,054 $ 17,214 $ (76,268 ) $ 48,438 Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities: Equity in earnings of subsidiaries (76,268 ) — — 76,268 — Depreciation and amortization — 19,262 8,768 — 28,030 Amortization of debt issuance costs — 3,438 (220 ) — 3,218 Equity-based compensation expense 9,249 — — — 9,249 Deferred income tax (benefit) expense (798 ) 22,964 2,516 — 24,682 Loss from discontinued operations, net of taxes — (3 ) — — (3 ) Loss (gain) on foreign currency derivatives 908 — — — 908 Other — 662 30 — 692 Change in operating assets and liabilities, net of effect of acquisitions: — Accounts receivable, net — (11,409 ) 967 — (10,442 ) Other current assets — (12,026 ) (1,022 ) — (13,048 ) Other assets (300 ) (1,220 ) 2 300 (1,218 ) Accounts payable and other accrued liabilities — 5,991 (10,304 ) — (4,313 ) Accrued salaries and benefits — 791 (1,016 ) — (225 ) Other liabilities — 5,442 (823 ) — 4,619 Net cash (used in) provided by continuing operating activities (18,771 ) 92,946 16,112 300 90,587 Net cash provided by discontinued operating activities — 554 — — 554 Net cash (used in) provided by operating activities (18,771 ) 93,500 16,112 300 91,141 Investing activities: — Cash paid for acquisitions, net of cash acquired — (89,041 ) (197,693 ) — (286,734 ) Cash paid for capital expenditures — (62,101 ) (59,934 ) — (122,035 ) Cash paid for real estate acquisitions — (3,428 ) — — (3,428 ) Settlement of foreign currency derivatives — (908 ) — — (908 ) Other — (481 ) — — (481 ) Net cash used in investing activities — (155,959 ) (257,627 ) — (413,586 ) Financing activities: — Borrowings on long-term debt 875,000 — — — 875,000 Borrowings on revolving credit facility 180,000 — — — 180,000 Principal payments on revolving credit facility (180,000 ) — — — (180,000 ) Repayment of assumed CRC debt (904,467 ) — — — (904,467 ) Principal payments on long-term debt (15,875 ) — (300 ) 300 (15,875 ) Payment of debt issuance costs — (22,775 ) — — (22,775 ) Issuance of Common Stock — 331,530 — — 331,530 Common stock withheld for minimum statutory taxes, net — (7,826 ) — — (7,826 ) Excess tax benefit from equity awards — 6,327 — — 6,327 Other — (150 ) — — (150 ) Cash provided by (used in) intercompany activity 64,113 (305,366 ) 241,853 (600 ) — Net cash provided by (used in) financing activities 18,771 1,740 241,553 (300 ) 261,764 Effect of exchange rate changes on cash — 1,213 — — 1,213 Net (decrease) increase in cash and cash equivalents — (59,506 ) 38 — (59,468 ) Cash and cash equivalents at beginning of the period — 76,685 17,355 — 94,040 Cash and cash equivalents at end of the period $ — $ 17,179 $ 17,393 $ — $ 34,572 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Cash Flows Six Months Ended June 30, 2014 (In thousands) Parent Combined Combined Consolidating Total Operating activities: Net income (loss) $ 35,509 $ 37,848 $ 2,991 $ (40,839 ) $ 35,509 Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities: Equity in earnings of subsidiaries (40,839 ) — — 40,839 — Depreciation and amortization — 10,666 705 — 11,371 Amortization of debt issuance costs 1,560 — (226 ) — 1,334 Equity-based compensation expense 4,170 — — — 4,170 Deferred income tax expense 5,585 3,105 407 — 9,097 Income from discontinued operations, net of taxes — (31 ) — — (31 ) Gain on foreign currency derivatives (13,735 ) — — — (13,735 ) Other — 25 — — 25 Change in operating assets and liabilities, net of effect of acquisitions: Accounts receivable, net — (16,670 ) 1,367 — (15,303 ) Other current assets — (5,033 ) 241 — (4,792 ) Other assets 165 (578 ) — (165 ) (578 ) Accounts payable and other accrued liabilities — (1,584 ) 284 — (1,300 ) Accrued salaries and benefits — 1,701 81 — 1,782 Other liabilities — 1,701 — — 1,701 Net cash (used in) provided by continuing operating activities (7,585 ) 31,150 5,850 (165 ) 29,250 Net cash used in discontinued operating activities — (11 ) — — (11 ) Net cash (used in) provided by operating activities (7,585 ) 31,139 5,850 (165 ) 29,239 Investing activities: Cash paid for acquisitions, net of cash acquired — (10,000 ) — — (10,000 ) Cash paid for capital expenditures — (39,782 ) (3,541 ) — (43,323 ) Cash paid for real estate acquisitions — (18,326 ) — — (18,326 ) Other — (439 ) — — (439 ) Net cash used in investing activities — (68,547 ) (3,541 ) — (72,088 ) Financing activities: Borrowings on long-term debt 7,500 — — — 7,500 Borrowings on revolving credit facility 59,500 — — — 59,500 Principal payments on revolving credit facility (113,000 ) — — — (113,000 ) Principal payments on long-term debt (3,750 ) — (165 ) 165 (3,750 ) Payment of debt issuance costs (5,810 ) — — — (5,810 ) Issuance of common stock, net 374,336 — — — 374,336 Common stock withheld for minimum statutory taxes, net (2,981 ) — — — (2,981 ) Excess tax benefit from equity awards 3,479 — — — 3,479 Cash paid for contingent consideration — (3,250 ) — — (3,250 ) Cash (used in) provided by intercompany activity (311,689 ) 315,175 (5,411 ) 1,925 — Net cash provided by (used in) financing activities 7,585 311,925 (5,576 ) 2,090 316,024 Net increase (decrease) in cash and cash equivalents — 274,517 (3,267 ) 1,925 273,175 Cash and cash equivalents at beginning of the period — — 6,494 (1,925 ) 4,569 Cash and cash equivalents at end of the period $ — $ 274,517 $ 3,227 $ — $ 277,744

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2015
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2015 and 2014 (in thousands except per share amounts): Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Numerator: Basic and diluted earnings per share: Income from continuing operations $ 33,843 $ 22,457 $ 48,435 $ 35,478 Income (loss) from discontinued operations 1 (6 ) 3 31 Net income $ 33,844 $ 22,451 $ 48,438 $ 35,509 Denominator: Weighted average shares outstanding for basic earnings per share 68,296 51,616 65,429 50,872 Effect of dilutive instruments 439 203 353 302 Shares used in computing diluted earnings per common share 68,735 51,819 65,782 51,174 Basic earnings per share: Income from continuing operations $ 0.50 $ 0.43 $ 0.74 $ 0.70 Income (loss) from discontinued operations — — — — Net income $ 0.50 $ 0.43 $ 0.74 $ 0.70 Diluted earnings per share: Income from continuing operations $ 0.49 $ 0.43 $ 0.74 $ 0.69 Income (loss) from discontinued operations — — — — Net income $ 0.49 $ 0.43 $ 0.74 $ 0.69

Acquisitions (Tables)

Acquisitions (Tables)	6 Months Ended
	Jun. 30, 2015
Preliminary Fair Values of Assets Acquired and Liabilities Assumed at Corresponding Acquisition Date	The preliminary fair values of assets acquired and liabilities assumed, at the corresponding acquisition dates, during the year ended December 31, 2014 in connection with the 2014 acquisitions were as follows (in thousands): Partnerships in Care Other Total Cash $ 11,674 $ — $ 11,674 Accounts receivable 7,684 1,849 9,533 Prepaid expenses and other current assets 8,828 169 8,997 Property and equipment 610,477 27,203 637,680 Goodwill 87,047 32,232 119,279 Intangible assets 651 204 855 Other assets 7,037 3,240 10,277 Total assets acquired 733,398 64,897 798,295 Accounts payable 3,958 93 4,051 Accrued salaries and benefits 10,422 — 10,422 Other accrued expenses 7,166 1,014 8,180 Deferred tax liabilities – noncurrent 15,597 — 15,597 Other liabilities 7,704 — 7,704 Total liabilities assumed 44,847 1,107 45,954 Net assets acquired $ 688,551 $ 63,790 $ 752,341
Transaction Related Expenses as Incurred	Transaction-related expenses comprised the following costs for the three and six months ended June 30, 2015 and 2014 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Advisory and financing commitment fees $ — $ — $ 10,337 $ — Legal, accounting and other costs 5,234 3,016 9,054 4,136 Severance and contract termination costs 1,923 — 6,182 459 $ 7,157 $ 3,016 $ 25,573 $ 4,595
Pro Forma Financial Information for Acquisitions Occurred	The following table provides certain pro forma financial information for the Company as if the 2014 and 2015 Acquisitions occurred as of January 1, 2014 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Revenue $ 461,128 $ 431,663 $ 901,582 $ 841,767 Income from continuing operations, before income taxes $ 51,123 $ 32,289 $ 39,293 $ 31,198
Crc Health Group Inc and Other Acquisitions [Member]
Preliminary Fair Values of Assets Acquired and Liabilities Assumed at Corresponding Acquisition Date	The preliminary fair values of assets acquired and liabilities assumed, at the corresponding acquisition dates, during the six months ended June 30, 2015 in connection with the 2015 acquisitions were as follows (in thousands): CRC Other Total Cash $ 19,600 $ 4,468 $ 24,068 Accounts receivable 47,095 6,130 53,225 Prepaid expenses and other current assets 25,522 1,380 26,902 Property and equipment 140,152 138,613 278,765 Goodwill 1,050,620 118,486 1,169,106 Intangible assets 37,000 — 37,000 Deferred tax assets – noncurrent 64,688 — 64,688 Other assets 6,478 — 6,478 Total assets acquired 1,391,155 269,077 1,660,232 Accounts payable 5,301 7,114 12,415 Accrued salaries and benefits 14,860 1,642 16,502 Other accrued expenses 38,703 2,546 41,249 Deferred tax liabilities – noncurrent — 1,052 1,052 Long-term debt 904,467 — 904,467 Other liabilities 34,248 11 34,259 Total liabilities assumed 997,579 12,365 1,009,944 Net assets acquired $ 393,576 $ 256,712 $ 650,288

Other Intangible Assets (Tables

Other Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Other Identifiable Intangible Assets and Related Accumulated Amortization	Other identifiable intangible assets and related accumulated amortization consisted of the following as of June 30, 2015 and December 31, 2014 (in thousands): Gross Carrying Amount Accumulated Amortization June 30, December 31, June 30, December 31, Intangible assets subject to amortization: Contract intangible assets $ 2,100 $ 2,100 $ (1,540 ) $ (1,330 ) Non-compete agreements 1,247 1,247 (1,205 ) (1,155 ) 3,347 3,347 (2,745 ) (2,485 ) Intangible assets not subject to amortization: Licenses and accreditations 10,318 9,184 — — Trade names 37,800 3,000 — — Certificates of need 9,794 8,590 — — 57,912 20,774 — — Total $ 61,259 $ 24,121 $ (2,745 ) $ (2,485 )

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2015
Text Block [Abstract]
Summary of Property and Equipment	Property and equipment consists of the following as of June 30, 2015 and December 31, 2014 (in thousands): June 30, 2015 December 31, 2014 Land $ 201,362 $ 132,406 Building and improvements 1,102,767 858,055 Equipment 118,736 73,584 Construction in progress 117,930 66,268 1,540,795 1,130,313 Less accumulated depreciation (85,405 ) (60,613 ) Property and equipment, net $ 1,455,390 $ 1,069,700

Long-Term Debt (Tables)

Long-Term Debt (Tables)	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Components of Long-Term Debt	Long-term debt consisted of the following (in thousands): June 30, 2015 December 31, 2014 Amended and Restated Senior Credit Facility: Senior Secured Term A Loans (net of discount of $1,628 and $1,924, respectively) $ 512,497 $ 525,576 Senior Secured Term B Loans (net of discount of $2,377) 495,123 — Senior Secured Revolving Line of Credit — — 12.875% Senior Notes due 2018 (net of discount of $967 and $1,080, respectively) 96,533 96,420 6.125% Senior Notes due 2021 150,000 150,000 5.125% Senior Notes due 2022 300,000 300,000 5.625% Senior Notes due 2023 375,000 — 9.0% and 9.5% Revenue Bonds (net of premium of $1,429 and $1,649, respectively) 24,054 24,274 1,953,207 1,096,270 Less: current portion (38,652 ) (26,965 ) Long-term debt $ 1,914,555 $ 1,069,305

Equity-Based Compensation (Tabl

Equity-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Option Activity	Stock option activity during 2014 and 2015 was as follows (aggregate intrinsic value in thousands): Number Weighted Weighted Aggregate Options outstanding at January 1, 2014 798,809 $ 21.93 8.20 $ 10,700 Options granted 226,663 49.80 9.25 209 Options exercised (210,199 ) 14.93 N/A 4,994 Options cancelled (77,851 ) 27.85 N/A N/A Options outstanding at December 31, 2014 737,422 32.19 8.09 14,512 Options granted 190,900 62.37 9.68 1,148 Options exercised (49,045 ) 23.66 N/A 5,197 Options cancelled (88,264 ) 47.86 N/A N/A Options outstanding at June 30, 2015 791,013 $ 40.28 8.09 $ 23,104 Options exercisable at December 31, 2014 91,947 $ 28.87 6.30 $ 3,326 Options exercisable at June 30, 2015 153,900 $ 34.84 6.60 $ 6,941
Restricted Stock Activity	Restricted stock activity during 2014 and 2015 was as follows: Number of Weighted Grant-Date Unvested at January 1, 2014 461,697 $ 24.96 Granted 468,484 48.99 Cancelled (75,369 ) 36.36 Vested (132,784 ) 22.81 Unvested at December 31, 2014 722,028 $ 39.77 Granted 480,152 62.08 Cancelled (55,674 ) 49.59 Vested (107,263 ) 32.47 Unvested at June 30, 2015 1,039,243 $ 51.03
Restricted Stock Unit Activity	Restricted stock unit activity during 2014 and 2015 was as follows: Number of Weighted Grant-Date Unvested at January 1, 2014 95,751 $ 23.05 Granted 108,449 50.75 Cancelled — — Vested (79,087 ) 21.81 Unvested at December 31, 2014 125,113 $ 38.73 Granted 217,994 61.77 Cancelled — — Vested (125,023 ) 32.38 Unvested at June 30, 2015 218,084 $ 56.97
Schedule of Stock Options Valuation Assumptions	The following table summarizes the grant-date fair value of options and the assumptions used to develop the fair value estimates for options granted during the six months ended June 30, 2015 and year ended December 31, 2014: June 30, 2015 December 31, 2014 Weighted average grant-date fair value of options $ 24.30 $ 17.14 Risk-free interest rate 1.9 % 1.7 % Expected volatility 33 % 36 % Expected life (in years) 5.5 5.5

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Carrying Amounts and Fair Values of Company's Amended and Restated Senior Credit Facilities and Contingent Consideration Liability	The carrying amounts and fair values of the Company’s Amended and Restated Senior Credit Facility, 12.875% Senior Notes, 6.125% Senior Notes, 5.125% Senior Notes, 5.625% Senior Notes, 9.0% and 9.5% Revenue Bonds and contingent consideration liabilities as of June 30, 2015 and December 31, 2014 were as follows (in thousands): Carrying Amount Fair Value June 30, December 31, June 30, December 31, Amended and Restated Senior Credit Facility $ 1,007,620 $ 525,576 $ 1,007,620 $ 525,576 12.875% Senior Notes due 2018 $ 96,533 $ 96,420 $ 106,519 $ 109,688 6.125% Senior Notes due 2021 $ 150,000 $ 150,000 $ 154,500 $ 153,000 5.125% Senior Notes due 2022 $ 300,000 $ 300,000 $ 297,750 $ 295,500 5.625% Senior Notes due 2023 $ 375,000 — $ 379,688 — 9.0% and 9.5% Revenue Bonds $ 24,054 $ 24,274 $ 24,054 $ 24,274 Contingent consideration liabilities $ 3,000 $ 3,000 $ 3,000 $ 3,000

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2015
Summary of Reconciliation of Segment EBITDA to Income from Continuing Operations	The following tables set forth the financial information by operating segment, including a reconciliation of Segment EBITDA to income from continuing operations before income taxes (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Revenue: U.S. Facilities $ 366,886 $ 212,834 $ 657,393 $ 413,398 U.K. Facilities 84,927 — 158,242 — Corporate and Other 1,847 969 3,808 1,823 $ 453,660 $ 213,803 $ 819,443 $ 415,221 Segment EBITDA (1): U.S. Facilities $ 102,342 $ 53,031 $ 178,706 $ 100,563 U.K. Facilities 20,371 — 39,182 — Corporate and Other (16,910 ) (8,317 ) (33,373 ) (16,567 ) $ 105,803 $ 44,714 $ 184,515 $ 83,996 Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Segment EBITDA (1) $ 105,803 $ 44,714 $ 184,515 $ 83,996 Plus (less): Equity-based compensation expense (5,355 ) (2,406 ) (9,249 ) (4,170 ) (Loss) gain on foreign currency derivatives (961 ) 13,735 (908 ) 13,735 Transaction-related expenses (7,157 ) (3,016 ) (25,573 ) (4,595 ) Interest expense, net (28,049 ) (9,730 ) (50,195 ) (19,437 ) Depreciation and amortization (14,926 ) (5,935 ) (28,030 ) (11,371 ) Income from continuing operations before income taxes $ 49,355 $ 37,362 $ 70,560 $ 58,158
Summary of Assets by Operating Segment	June 30, 2015 December 31, 2014 Assets (2): U.S. Facilities $ 2,729,896 $ 1,327,563 U.K. Facilities 944,033 726,693 Corporate and Other 252,456 169,334 $ 3,926,385 $ 2,223,590
Goodwill [Member]
Summary of Assets by Operating Segment	U.S. Facilities U.K. Facilities Corporate Consolidated Goodwill: Balance at January 1, 2015 $ 693,945 $ 109,041 $ — $ 802,986 Increase from 2015 acquisitions 1,103,813 65,293 — 1,169,106 Foreign currency translation — 6,972 — 6,972 Purchase price allocation and other 281 (33,317 ) — (33,036 ) Balance at June 30, 2015 $ 1,798,039 $ 147,989 $ — $ 1,946,028

Financial Information for the33

Financial Information for the Company and Its Subsidiaries (Tables)	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Condensed Consolidating Balance Sheets	Acadia Healthcare Company, Inc. Condensed Consolidating Balance Sheets June 30, 2015 (In thousands) Parent Combined Combined Consolidating Total Current assets: Cash and cash equivalents $ — $ 17,179 $ 17,393 $ — $ 34,572 Accounts receivable, net — 160,179 22,136 — 182,315 Deferred tax assets — 36,502 2,191 — 38,693 Other current assets — 62,295 8,030 — 70,325 Total current assets — 276,155 49,750 — 325,905 Property and equipment, net — 656,262 799,128 — 1,455,390 Goodwill — 1,700,705 245,323 — 1,946,028 Intangible assets, net — 55,928 2,586 — 58,514 Deferred tax assets – noncurrent 5,361 16,239 12,366 — 33,966 Investment in subsidiaries 1,332,308 — — (1,332,308 ) — Other assets 389,676 65,957 2,322 (351,373 ) 106,582 Total assets $ 1,727,345 $ 2,771,246 $ 1,111,475 $ (1,683,681 ) $ 3,926,385 Current liabilities: Current portion of long-term debt $ 38,437 $ — $ 215 $ — $ 38,652 Accounts payable — 44,985 13,729 — 58,714 Accrued salaries and benefits — 65,040 12,505 — 77,545 Other accrued liabilities 22,604 27,543 18,050 — 68,197 Total current liabilities 61,041 137,568 44,499 — 243,108 Long-term debt — 1,890,716 375,212 (351,373 ) 1,914,555 Deferred tax liabilities – noncurrent — — 20,200 — 20,200 Other liabilities — 72,329 9,889 — 82,218 Total liabilities 61,041 2,100,613 449,800 (351,373 ) 2,260,081 Total equity 1,666,304 670,633 661,675 (1,332,308 ) 1,666,304 Total liabilities and equity $ 1,727,345 $ 2,771,246 $ 1,111,475 $ (1,683,681 ) $ 3,926,385 Acadia Healthcare Company, Inc. Condensed Consolidating Balance Sheets December 31, 2014 (In thousands) Parent Combined Combined Consolidating Total Current assets: Cash and cash equivalents $ — $ 76,685 $ 17,355 $ — $ 94,040 Accounts receivable, net — 100,797 17,581 — 118,378 Deferred tax assets — 18,395 1,760 — 20,155 Other current assets — 36,049 5,521 — 41,570 Total current assets — 231,926 42,217 — 274,143 Property and equipment, net — 451,943 617,757 — 1,069,700 Goodwill — 596,611 206,375 — 802,986 Intangible assets, net — 19,057 2,579 — 21,636 Deferred tax assets – noncurrent 4,563 — 14,244 (5,666 ) 13,141 Investment in subsidiaries 1,759,337 — — (1,759,337 ) — Other assets 202,708 18,727 2,323 (181,774 ) 41,984 Total assets $ 1,966,608 $ 1,318,264 $ 885,495 $ (1,946,777 ) $ 2,223,590 Current liabilities: Current portion of long-term debt $ 26,750 $ — $ 215 $ — $ 26,965 Accounts payable — 39,486 9,210 — 48,696 Accrued salaries and benefits — 47,597 11,720 — 59,317 Other accrued liabilities 13,647 7,688 9,621 — 30,956 Total current liabilities 40,397 94,771 30,766 — 165,934 Long-term debt 1,045,246 — 205,833 (181,774 ) 1,069,305 Deferred tax liabilities – noncurrent — 21,027 48,519 (5,666 ) 63,880 Other liabilities — 33,321 10,185 — 43,506 Total liabilities 1,085,643 149,119 295,303 (187,440 ) 1,342,625 Total equity 880,965 1,169,145 590,192 (1,759,337 ) 880,965 Total liabilities and equity $ 1,966,608 $ 1,318,264 $ 885,495 $ (1,946,777 ) $ 2,223,590
Summary of Condensed Consolidating Statement of Comprehensive Income	Condensed Consolidating Statement of Comprehensive Income Three Months Ended June 30, 2015 (In thousands) Parent Combined Combined Consolidating Total Revenue before provision for doubtful accounts $ — $ 363,851 $ 97,947 $ — $ 461,798 Provision for doubtful accounts — (7,566 ) (572 ) — (8,138 ) Revenue — 356,285 97,375 — 453,660 Salaries, wages and benefits 5,355 183,490 54,457 — 243,302 Professional fees — 22,579 7,450 — 30,029 Supplies — 16,929 3,613 — 20,542 Rents and leases — 7,402 809 — 8,211 Other operating expenses — 43,145 7,983 — 51,128 Depreciation and amortization — 10,551 4,375 — 14,926 Interest expense, net 18,106 5,882 4,061 — 28,049 Loss on foreign currency derivatives 961 — — — 961 Transaction-related expenses — 2,946 4,211 — 7,157 Total expenses 24,422 292,924 86,959 — 404,305 (Loss) income from continuing operations before income taxes (24,422 ) 63,361 10,416 — 49,355 Equity in earnings of subsidiaries 50,281 — — (50,281 ) — (Benefit from) provision for income taxes (7,985 ) 20,734 2,763 — 15,512 Income (loss) from continuing operations 33,844 42,627 7,653 (50,281 ) 33,843 Income from discontinued operations, net of income taxes — 1 — — 1 Net income (loss) $ 33,844 $ 42,628 $ 7,653 $ (50,281 ) $ 33,844 Other comprehensive income: Foreign currency translation gain — — 46,173 — 46,173 Other comprehensive income — — 46,173 — 46,173 Comprehensive income (loss) $ 33,844 $ 42,628 $ 53,826 $ (50,281 ) $ 80,017 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Comprehensive Income Three Months Ended June 30, 2014 (In thousands) Parent Combined Combined Consolidating Total Revenue before provision for doubtful accounts $ — $ 207,143 $ 13,521 $ — $ 220,664 Provision for doubtful accounts — (5,954 ) (907 ) — (6,861 ) Revenue — 201,189 12,614 — 213,803 Salaries, wages and benefits 2,406 114,976 5,091 — 122,473 Professional fees — 9,691 1,200 — 10,891 Supplies — 9,967 629 — 10,596 Rents and leases — 2,613 276 — 2,889 Other operating expenses — 22,522 2,124 — 24,646 Depreciation and amortization — 5,581 354 — 5,935 Interest expense, net 9,202 — 528 — 9,730 Loss (gain) on foreign currency derivatives (13,735 ) — — — (13,735 ) Transaction-related expenses — 3,016 — — 3,016 Total expenses (2,127 ) 168,366 10,202 — 176,441 Income from continuing operations before income taxes 2,127 32,823 2,412 — 37,362 Equity in earnings of subsidiaries 20,972 — — (20,972 ) — Provision for income taxes 648 13,315 942 — 14,905 Income (loss) from continuing operations 22,451 19,508 1,470 (20,972 ) 22,457 Loss from discontinued operations, net of income taxes — (6 ) — — (6 ) Net income (loss) $ 22,451 $ 19,502 $ 1,470 $ (20,972 ) $ 22,451 Comprehensive income (loss) $ 22,451 $ 19,502 $ 1,470 $ (20,972 ) $ 22,451 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Comprehensive Income Six Months Ended June 30, 2015 (In thousands) Parent Combined Combined Consolidating Total Revenue before provision for doubtful accounts $ — $ 651,616 $ 184,340 $ — $ 835,956 Provision for doubtful accounts — (14,985 ) (1,528 ) — (16,513 ) Revenue — 636,631 182,812 — 819,443 Salaries, wages and benefits 9,249 339,189 100,735 — 449,173 Professional fees — 39,064 13,392 — 52,456 Supplies — 29,938 6,858 — 36,796 Rents and leases — 12,519 1,578 — 14,097 Other operating expenses — 75,392 16,263 — 91,655 Depreciation and amortization — 19,262 8,768 — 28,030 Interest expense, net 31,054 11,603 7,538 — 50,195 Loss on foreign currency derivatives 908 — — — 908 Transaction-related expenses — 21,362 4,211 — 25,573 Total expenses 41,211 548,329 159,343 — 748,883 (Loss) income from continuing operations before income taxes (41,211 ) 88,302 23,469 — 70,560 Equity in earnings of subsidiaries 76,268 — — (76,268 ) — (Benefit from) provision for income taxes (13,381 ) 29,251 6,255 — 22,125 Income (loss) from continuing operations 48,438 59,051 17,214 (76,268 ) 48,435 Income from discontinued operations, net of income taxes — 3 — — 3 Net income (loss) $ 48,438 $ 59,054 $ 17,214 $ (76,268 ) $ 48,438 Other comprehensive income: Foreign currency translation gain — — 16,784 — 16,784 Other comprehensive income — — 16,784 — 16,784 Comprehensive income (loss) $ 48,438 $ 59,054 $ 33,998 $ (76,268 ) $ 65,222 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Comprehensive Income Six Months Ended June 30, 2014 (In thousands) Parent Combined Combined Consolidating Total Revenue before provision for doubtful accounts $ — $ 400,425 $ 26,358 $ — $ 426,783 Provision for doubtful accounts — (10,464 ) (1,098 ) — (11,562 ) Revenue — 389,961 25,260 — 415,221 Salaries, wages and benefits 4,170 225,629 10,249 — 240,048 Professional fees — 18,944 2,329 — 21,273 Supplies — 19,353 1,307 — 20,660 Rents and leases — 5,108 550 — 5,658 Other operating expenses — 43,600 4,156 — 47,756 Depreciation and amortization — 10,666 705 — 11,371 Interest expense, net 18,313 — 1,124 — 19,437 Loss (gain) on foreign currency derivatives (13,735 ) — — — (13,735 ) Transaction-related expenses — 4,595 — — 4,595 Total expenses 8,748 327,895 20,420 — 357,063 (Loss) income from continuing operations before income taxes (8,748 ) 62,066 4,840 — 58,158 Equity in earnings of subsidiaries 40,839 — — (40,839 ) — (Benefit from) provision for income taxes (3,418 ) 24,249 1,849 — 22,680 Income (loss) from continuing operations 35,509 37,817 2,991 (40,839 ) 35,478 Income from discontinued operations, net of income taxes — 31 — — 31 Net income (loss) $ 35,509 $ 37,848 $ 2,991 $ (40,839 ) $ 35,509 Comprehensive income (loss) $ 35,509 $ 37,848 $ 2,991 $ (40,839 ) $ 35,509
Summary of Condensed Consolidating Statement of Cash Flows	Condensed Consolidating Statement of Cash Flows Six Months Ended June 30, 2015 (In thousands) Parent Combined Combined Consolidating Total Operating activities: Net income (loss) $ 48,438 $ 59,054 $ 17,214 $ (76,268 ) $ 48,438 Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities: Equity in earnings of subsidiaries (76,268 ) — — 76,268 — Depreciation and amortization — 19,262 8,768 — 28,030 Amortization of debt issuance costs — 3,438 (220 ) — 3,218 Equity-based compensation expense 9,249 — — — 9,249 Deferred income tax (benefit) expense (798 ) 22,964 2,516 — 24,682 Loss from discontinued operations, net of taxes — (3 ) — — (3 ) Loss (gain) on foreign currency derivatives 908 — — — 908 Other — 662 30 — 692 Change in operating assets and liabilities, net of effect of acquisitions: — Accounts receivable, net — (11,409 ) 967 — (10,442 ) Other current assets — (12,026 ) (1,022 ) — (13,048 ) Other assets (300 ) (1,220 ) 2 300 (1,218 ) Accounts payable and other accrued liabilities — 5,991 (10,304 ) — (4,313 ) Accrued salaries and benefits — 791 (1,016 ) — (225 ) Other liabilities — 5,442 (823 ) — 4,619 Net cash (used in) provided by continuing operating activities (18,771 ) 92,946 16,112 300 90,587 Net cash provided by discontinued operating activities — 554 — — 554 Net cash (used in) provided by operating activities (18,771 ) 93,500 16,112 300 91,141 Investing activities: — Cash paid for acquisitions, net of cash acquired — (89,041 ) (197,693 ) — (286,734 ) Cash paid for capital expenditures — (62,101 ) (59,934 ) — (122,035 ) Cash paid for real estate acquisitions — (3,428 ) — — (3,428 ) Settlement of foreign currency derivatives — (908 ) — — (908 ) Other — (481 ) — — (481 ) Net cash used in investing activities — (155,959 ) (257,627 ) — (413,586 ) Financing activities: — Borrowings on long-term debt 875,000 — — — 875,000 Borrowings on revolving credit facility 180,000 — — — 180,000 Principal payments on revolving credit facility (180,000 ) — — — (180,000 ) Repayment of assumed CRC debt (904,467 ) — — — (904,467 ) Principal payments on long-term debt (15,875 ) — (300 ) 300 (15,875 ) Payment of debt issuance costs — (22,775 ) — — (22,775 ) Issuance of Common Stock — 331,530 — — 331,530 Common stock withheld for minimum statutory taxes, net — (7,826 ) — — (7,826 ) Excess tax benefit from equity awards — 6,327 — — 6,327 Other — (150 ) — — (150 ) Cash provided by (used in) intercompany activity 64,113 (305,366 ) 241,853 (600 ) — Net cash provided by (used in) financing activities 18,771 1,740 241,553 (300 ) 261,764 Effect of exchange rate changes on cash — 1,213 — — 1,213 Net (decrease) increase in cash and cash equivalents — (59,506 ) 38 — (59,468 ) Cash and cash equivalents at beginning of the period — 76,685 17,355 — 94,040 Cash and cash equivalents at end of the period $ — $ 17,179 $ 17,393 $ — $ 34,572 Acadia Healthcare Company, Inc. Condensed Consolidating Statement of Cash Flows Six Months Ended June 30, 2014 (In thousands) Parent Combined Combined Consolidating Total Operating activities: Net income (loss) $ 35,509 $ 37,848 $ 2,991 $ (40,839 ) $ 35,509 Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities: Equity in earnings of subsidiaries (40,839 ) — — 40,839 — Depreciation and amortization — 10,666 705 — 11,371 Amortization of debt issuance costs 1,560 — (226 ) — 1,334 Equity-based compensation expense 4,170 — — — 4,170 Deferred income tax expense 5,585 3,105 407 — 9,097 Income from discontinued operations, net of taxes — (31 ) — — (31 ) Gain on foreign currency derivatives (13,735 ) — — — (13,735 ) Other — 25 — — 25 Change in operating assets and liabilities, net of effect of acquisitions: Accounts receivable, net — (16,670 ) 1,367 — (15,303 ) Other current assets — (5,033 ) 241 — (4,792 ) Other assets 165 (578 ) — (165 ) (578 ) Accounts payable and other accrued liabilities — (1,584 ) 284 — (1,300 ) Accrued salaries and benefits — 1,701 81 — 1,782 Other liabilities — 1,701 — — 1,701 Net cash (used in) provided by continuing operating activities (7,585 ) 31,150 5,850 (165 ) 29,250 Net cash used in discontinued operating activities — (11 ) — — (11 ) Net cash (used in) provided by operating activities (7,585 ) 31,139 5,850 (165 ) 29,239 Investing activities: Cash paid for acquisitions, net of cash acquired — (10,000 ) — — (10,000 ) Cash paid for capital expenditures — (39,782 ) (3,541 ) — (43,323 ) Cash paid for real estate acquisitions — (18,326 ) — — (18,326 ) Other — (439 ) — — (439 ) Net cash used in investing activities — (68,547 ) (3,541 ) — (72,088 ) Financing activities: Borrowings on long-term debt 7,500 — — — 7,500 Borrowings on revolving credit facility 59,500 — — — 59,500 Principal payments on revolving credit facility (113,000 ) — — — (113,000 ) Principal payments on long-term debt (3,750 ) — (165 ) 165 (3,750 ) Payment of debt issuance costs (5,810 ) — — — (5,810 ) Issuance of common stock, net 374,336 — — — 374,336 Common stock withheld for minimum statutory taxes, net (2,981 ) — — — (2,981 ) Excess tax benefit from equity awards 3,479 — — — 3,479 Cash paid for contingent consideration — (3,250 ) — — (3,250 ) Cash (used in) provided by intercompany activity (311,689 ) 315,175 (5,411 ) 1,925 — Net cash provided by (used in) financing activities 7,585 311,925 (5,576 ) 2,090 316,024 Net increase (decrease) in cash and cash equivalents — 274,517 (3,267 ) 1,925 273,175 Cash and cash equivalents at beginning of the period — — 6,494 (1,925 ) 4,569 Cash and cash equivalents at end of the period $ — $ 274,517 $ 3,227 $ — $ 277,744

Description of Business and B34

Description of Business and Basis of Presentation - Additional Information (Detail) - Jun. 30, 2015	BedsStateFacilities
Accounting Policies [Abstract]
Number of facilities | Facilities	223
Number of beds | Beds	9,000
Number of operating states	37
Percentage of ownership in subsidiaries	100.00%

Earnings Per Share - Computatio

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Basic and diluted earnings per share:
Income from continuing operations	$ 33,843	$ 22,457	$ 48,435	$ 35,478
Income (loss) from discontinued operations	1	(6)	3	31
Net income	$ 33,844	$ 22,451	$ 48,438	$ 35,509
Denominator:
Weighted average shares outstanding for basic earnings per share	68,296	51,616	65,429	50,872
Effect of dilutive instruments	439	203	353	302
Shares used in computing diluted earnings per common share	68,735	51,819	65,782	51,174
Basic earnings per share:
Income from continuing operations	$ 0.50	$ 0.43	$ 0.74	$ 0.70
Income (loss) from discontinued operations	0	0	0	0
Net income	0.50	0.43	0.74	0.70
Diluted earnings per share:
Income from continuing operations	0.49	0.43	0.74	0.69
Income (loss) from discontinued operations	0	0	0	0
Net income	$ 0.49	$ 0.43	$ 0.74	$ 0.69

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) - shares shares in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Earnings Per Share [Abstract]
Excluded common stock for computation of diluted earnings per share	0.3	0.6	0.9	0.5

Acquisitions - UK Acquisitions

Acquisitions - UK Acquisitions (Detail) - United Kingdom [Member] $ in Millions	Jun. 01, 2015USD ($)BedsFacility	Apr. 01, 2015USD ($)BedsFacility
Care UK Limited [Member]
Business Acquisition [Line Items]
Business acquisition cash paid	$ 88.3
Number of facilities acquired | Facility	15
Number of beds | Beds	299
Choice Lifestyles [Member]
Business Acquisition [Line Items]
Business acquisition cash paid	$ 25.9	$ 37.5
Number of facilities acquired | Facility	1	2
Number of beds | Beds	42	48
Pastoral Care Group [Member]
Business Acquisition [Line Items]
Business acquisition cash paid		$ 34.2
Number of facilities acquired | Facility		2
Number of beds | Beds		65
Mildmay Oaks [Member]
Business Acquisition [Line Items]
Business acquisition cash paid		$ 14.9
Number of beds | Beds		67

Acquisitions - Recent Acquisiti

Acquisitions - Recent Acquisitions (Detail) - Mar. 01, 2015 - Quality Addiction Management [Member] $ in Millions	USD ($)Center
Business Acquisition [Line Items]
Business acquisition cash paid | $	$ 54.6
Number of facilities acquired	7

Acquisitions - CRC Acquisition

Acquisitions - CRC Acquisition (Detail) $ in Millions	Feb. 11, 2015USD ($)BedsStateCenterFacilitiesshares	Jun. 30, 2015State
Business Acquisition [Line Items]
Number of operating states		37
CRC Health Group, Inc [Member]
Business Acquisition [Line Items]
Total consideration related to acquisition | $	$ 1,300
Shares issued for acquisition | shares	5,975,326
Outstanding indebtedness of CRC repaid | $	$ 904.5
Number of inpatient facilities | Facilities	35
Number of operating states	30
Number of facilities acquired | Center	81
Minimum [Member] | CRC Health Group, Inc [Member]
Business Acquisition [Line Items]
Number of beds | Beds	2,400

Acquisitions - 2014 Acquisition

Acquisitions - 2014 Acquisitions (Detail) $ in Thousands	Dec. 31, 2014USD ($)Beds	Dec. 01, 2014USD ($)Beds	Sep. 03, 2014USD ($)Beds	Jul. 01, 2014USD ($)BedsFacilities	Jan. 01, 2014USD ($)Beds	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)
Business Acquisition [Line Items]
Gain on foreign currency derivatives						$ (961)	$ 13,735	$ (908)	$ 13,735
Croxton [Member] | 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Business acquisition cash paid		$ 15,600
Number of beds | Beds		24
Skyway [Member] | 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Business acquisition cash paid	$ 300
Number of beds | Beds	28
Acquisition completion date	Dec. 31, 2014
McCallum [Member] | 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Business acquisition cash paid			$ 37,400
Number of beds | Beds			85
Partnerships In Care [Member] | 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Acquisition completion date				Jul. 1, 2014
Number of inpatient psychiatric facilities | Facilities				23
Total consideration related to acquisition				$ 661,700
Cash from consideration related to acquisition				12,000
Gain on foreign currency derivatives				$ 15,300
Partnerships In Care [Member] | Minimum [Member] | 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Number of beds | Beds				1,200
Pacific Grove [Member] | 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Business acquisition cash paid					$ 10,500
Number of beds | Beds					68

Acquisitions - Summary of Acqui

Acquisitions - Summary of Acquisitions - Additional Information (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Business Acquisition [Line Items]
Goodwill associated with domestic acquisitions	$ 1,946,028	$ 802,986
Domestic Acquisitions in 2015 and 2014 [Member]
Business Acquisition [Line Items]
Goodwill associated with domestic acquisitions	$ 175,500	$ 175,500

Acquisitions - Summary of Acq42

Acquisitions - Summary of Acquisitions (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Business Acquisition [Line Items]
Goodwill	$ 1,946,028	$ 802,986
2014 Acquisitions [Member]
Business Acquisition [Line Items]
Cash		11,674
Accounts receivable		9,533
Prepaid expenses and other current assets		8,997
Property and equipment		637,680
Goodwill		119,279
Intangible assets		855
Other assets		10,277
Total assets acquired		798,295
Accounts payable		4,051
Accrued salaries and benefits		10,422
Other accrued expenses		8,180
Deferred tax liabilities - noncurrent		15,597
Other liabilities		7,704
Total liabilities assumed		45,954
Net assets acquired		752,341
2015 Acquisitions [Member]
Business Acquisition [Line Items]
Cash	24,068
Accounts receivable	53,225
Prepaid expenses and other current assets	26,902
Property and equipment	278,765
Goodwill	1,169,106
Intangible assets	37,000
Deferred tax assets - noncurrent	64,688
Other assets	6,478
Total assets acquired	1,660,232
Accounts payable	12,415
Accrued salaries and benefits	16,502
Other accrued expenses	41,249
Deferred tax liabilities - noncurrent	1,052
Long-term debt	904,467
Other liabilities	34,259
Total liabilities assumed	1,009,944
Net assets acquired	650,288
Partnerships In Care [Member] | 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Cash		11,674
Accounts receivable		7,684
Prepaid expenses and other current assets		8,828
Property and equipment		610,477
Goodwill		87,047
Intangible assets		651
Other assets		7,037
Total assets acquired		733,398
Accounts payable		3,958
Accrued salaries and benefits		10,422
Other accrued expenses		7,166
Deferred tax liabilities - noncurrent		15,597
Other liabilities		7,704
Total liabilities assumed		44,847
Net assets acquired		688,551
Other [Member] | 2014 Acquisitions [Member]
Business Acquisition [Line Items]
Accounts receivable		1,849
Prepaid expenses and other current assets		169
Property and equipment		27,203
Goodwill		32,232
Intangible assets		204
Other assets		3,240
Total assets acquired		64,897
Accounts payable		93
Other accrued expenses		1,014
Total liabilities assumed		1,107
Net assets acquired		$ 63,790
Other [Member] | 2015 Acquisitions [Member]
Business Acquisition [Line Items]
Cash	4,468
Accounts receivable	6,130
Prepaid expenses and other current assets	1,380
Property and equipment	138,613
Goodwill	118,486
Total assets acquired	269,077
Accounts payable	7,114
Accrued salaries and benefits	1,642
Other accrued expenses	2,546
Deferred tax liabilities - noncurrent	1,052
Other liabilities	11
Total liabilities assumed	12,365
Net assets acquired	256,712
CRC Health Group, Inc [Member] | 2015 Acquisitions [Member]
Business Acquisition [Line Items]
Cash	19,600
Accounts receivable	47,095
Prepaid expenses and other current assets	25,522
Property and equipment	140,152
Goodwill	1,050,620
Intangible assets	37,000
Deferred tax assets - noncurrent	64,688
Other assets	6,478
Total assets acquired	1,391,155
Accounts payable	5,301
Accrued salaries and benefits	14,860
Other accrued expenses	38,703
Long-term debt	904,467
Other liabilities	34,248
Total liabilities assumed	997,579
Net assets acquired	$ 393,576

Acquisitions - Other (Detail)

Acquisitions - Other (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Business Combinations [Abstract]
Advisory and financing commitment fees			$ 10,337
Legal, accounting and other costs	$ 5,234	$ 3,016	9,054	$ 4,136
Severance and contract termination costs	1,923		6,182	459
Transaction-related expenses	$ 7,157	$ 3,016	$ 25,573	$ 4,595

Acquisitions - Pro Forma Inform

Acquisitions - Pro Forma Information 1 (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Business Acquisition [Line Items]
Revenue	$ 453,660	$ 213,803	$ 819,443	$ 415,221
Income (loss) from continuing operations	49,355	37,362	70,560	58,158
Acquisitions Completed in 2014 And 2015 [Member]
Business Acquisition [Line Items]
Revenue	222,100		369,700
Income (loss) from continuing operations	$ 37,600		$ 58,100
Acquisitions Completed in 2014 [Member]
Business Acquisition [Line Items]
Revenue		1,600		2,900
Income (loss) from continuing operations		$ 100		$ (100)

Acquisitions - Pro Forma Info45

Acquisitions - Pro Forma Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Business Combinations [Abstract]
Revenue	$ 461,128	$ 431,663	$ 901,582	$ 841,767
Income from continuing operations, before income taxes	$ 51,123	$ 32,289	$ 39,293	$ 31,198

Other Intangible Assets - Other

Other Intangible Assets - Other Identifiable Intangible Assets and Related Accumulated Amortization (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross Carrying Amount	$ 3,347	$ 3,347
Intangible assets not subject to amortization, Gross Carrying Amount	57,912	20,774
Total	61,259	24,121
Intangible assets subject to amortization, Accumulated Amortization	(2,745)	(2,485)
Contract Intangible Assets [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross Carrying Amount	2,100	2,100
Intangible assets subject to amortization, Accumulated Amortization	(1,540)	(1,330)
Non-Compete Agreements [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets subject to amortization, Gross Carrying Amount	1,247	1,247
Intangible assets subject to amortization, Accumulated Amortization	(1,205)	(1,155)
Licenses and Accreditations [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets not subject to amortization, Gross Carrying Amount	10,318	9,184
Trade Names [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets not subject to amortization, Gross Carrying Amount	37,800	3,000
Certificates of Need [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Intangible assets not subject to amortization, Gross Carrying Amount	$ 9,794	$ 8,590

Other Intangible Assets - Addit

Other Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Amortization expense	$ 0.1	$ 0.1	$ 0.3	$ 0.3
Estimated amortization expense, remainder of 2015	0.5		0.5
Estimated amortization expense, 2016	0.4		0.4
Estimated amortization expense, 2017	0		0
Estimated amortization expense, 2018	0		0
Estimated amortization expense, 2019	$ 0		0
Licenses and Accreditations [Member] | CRC Health Group, Inc [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Acquisition of intangible assets with a preliminary fair value			1.1
Trade Names [Member] | CRC Health Group, Inc [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Acquisition of intangible assets with a preliminary fair value			34.8
Certificates of Need [Member] | CRC Health Group, Inc [Member]
Schedule Of Finite and Indefinite Lived Other Intangible Assets [Line Items]
Acquisition of intangible assets with a preliminary fair value			$ 1.1

Property and Equipment - Summar

Property and Equipment - Summary of Property and Equipment (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,540,795	$ 1,130,313
Less accumulated depreciation	(85,405)	(60,613)
Property and equipment, net	1,455,390	1,069,700
Land [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	201,362	132,406
Building and Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,102,767	858,055
Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	118,736	73,584
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 117,930	$ 66,268

Long-Term Debt - Components of

Long-Term Debt - Components of Long-Term Debt (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Long-term debt	$ 1,953,207	$ 1,096,270
Long-term debt	1,953,207	1,096,270
Less: current portion	(38,652)	(26,965)
Long-term debt	1,914,555	1,069,305
Amended and Restated Senior Credit Facility [Member] | Senior Secured Term A Loans [Member]
Debt Instrument [Line Items]
Senior Secured	512,497	525,576
Amended and Restated Senior Credit Facility [Member] | Senior Secured Term B Loans [Member]
Debt Instrument [Line Items]
Senior Secured	495,123
12.875% Senior Notes Due 2018 [Member]
Debt Instrument [Line Items]
Senior Notes	96,533	96,420
6.125% Senior Notes Due 2021 [Member]
Debt Instrument [Line Items]
Senior Notes	150,000	150,000
5.125% Senior Notes due 2022 [Member]
Debt Instrument [Line Items]
Senior Notes	300,000	300,000
5.625% Senior Notes Due 2023 [Member]
Debt Instrument [Line Items]
Senior Notes	375,000
9.0% and 9.5% Revenue Bonds [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	$ 24,054	$ 24,274

Long-Term Debt - Components o50

Long-Term Debt - Components of Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Feb. 11, 2015	Jul. 01, 2014	Mar. 12, 2013	Nov. 01, 2011
12.875% Senior Notes Due 2018 [Member]
Debt Instrument [Line Items]
Debt instrument interest rate	12.875%	12.875%			12.875%	12.875%
Senior notes maturity year	2,018	2,018
Debt instrument discount	$ 967	$ 1,080				$ 2,500
6.125% Senior Notes Due 2021 [Member]
Debt Instrument [Line Items]
Debt instrument interest rate	6.125%	6.125%			6.125%
Senior notes maturity year	2,021	2,021
5.125% Senior Notes due 2022 [Member]
Debt Instrument [Line Items]
Debt instrument interest rate	5.125%	5.125%		5.125%
Senior notes maturity year	2,022	2,022
5.625% Senior Notes Due 2023 [Member]
Debt Instrument [Line Items]
Debt instrument interest rate	5.625%	5.625%	5.625%
Senior notes maturity year	2,023	2,023
9.0% and 9.5% Revenue Bonds [Member]
Debt Instrument [Line Items]
Debt instrument premium	$ 1,429	$ 1,649
9.0% Revenue Bonds [Member]
Debt Instrument [Line Items]
Debt instrument interest rate	9.00%	9.00%
9.5% Revenue Bonds [Member]
Debt Instrument [Line Items]
Debt instrument interest rate	9.50%	9.50%
Senior Secured Term A Loans [Member] | Amended and Restated Senior Credit Facility [Member]
Debt Instrument [Line Items]
Debt instrument discount	$ 1,628	$ 1,924
Senior Secured Term B Loans [Member] | Amended and Restated Senior Credit Facility [Member]
Debt Instrument [Line Items]
Debt instrument discount	$ 2,377

Long-Term Debt (Amended and Res

Long-Term Debt (Amended and Restated Senior Credit Facility) - Additional Information (Detail) - USD ($)

Dec. 15, 2014

Jun. 16, 2014

Feb. 13, 2014

Dec. 31, 2012

Apr. 01, 2011

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Feb. 12, 2014

Jun. 30, 2015

Feb. 11, 2015

Feb. 06, 2015

Debt Instrument [Line Items]

Quarterly term loan principal payment

$ 180,000,000

$ 113,000,000

Amended and Restated Senior Credit Facility [Member]

Debt Instrument [Line Items]

Date entered into an agreement

Dec. 15, 2014

Feb. 13, 2014

Dec. 31, 2012

Apr. 1, 2011

Amount available under revolving line of credit

$ 291,100,000

$ 291,100,000

Debt instrument maturity date

Feb. 13, 2019

Feb. 11, 2022

Quarterly term loan principal payment

$ 1,900,000

Term loan repayments

$ 1,300,000

Consolidated funded debt, unrestricted and unencumbered cash to consolidated EBITDA

40,000,000

Commitment fee for undrawn amounts

0.50%

0.40%

Amended and Restated Senior Credit Facility [Member] | Miscellaneous Investments [Member]

Debt Instrument [Line Items]

Date entered into an agreement

Jun. 16, 2014

Restrictive covenants on investments, Description

The Company may now invest, in any given fiscal year, up to five percent (5%) of its total assets in both joint ventures and foreign subsidiaries, respectively; provided that the aggregate amount of investments in both joint ventures and foreign subsidiaries, respectively, may not exceed ten percent (10%) of its total assets over the life of the Amended and Restated Senior Credit Facility; provided further that the aggregate amount of investments made in both joint ventures and foreign subsidiaries collectively pursuant to the foregoing may not exceed fifteen percent (15%) of its total assets.

Amended and Restated Senior Credit Facility [Member] | Scenario, Plan [Member]

Debt Instrument [Line Items]

Additional term loans

$ 150,000,000

Line of Credit Facility, Increase (Decrease) for Period, Description

The Fourth Amendment also provides for a $150.0 million incremental credit facility, with the potential for unlimited additional incremental amounts, provided the Company meets certain financial ratios, in each case subject to customary conditions precedent to borrowing.

Amended and Restated Senior Credit Facility [Member] | Senior Secured Term A Loans [Member]

Debt Instrument [Line Items]

Line of credit

300,000,000

Additional term loans

235,000,000

Amended and Restated Senior Credit Facility [Member] | Senior Secured Revolving Line of Credit [Member]

Debt Instrument [Line Items]

Line of credit

$ 300,000,000

Amended and Restated Senior Credit Facility [Member] | Seventh Amendment [Member]

Debt Instrument [Line Items]

Date entered into an agreement

Feb. 6, 2015

Amended and Restated Senior Credit Facility [Member] | Letter of Credit [Member] | Seventh Amendment [Member]

Debt Instrument [Line Items]

Line of credit

$ 20,000,000

Amended and Restated Senior Credit Facility [Member] | Swing Line Sublimit [Member] | Seventh Amendment [Member]

Debt Instrument [Line Items]

Line of credit

$ 20,000,000

Amended and Restated Senior Credit Facility [Member] | Eurodollar [Member]

Debt Instrument [Line Items]

Interest on borrowings

3.25%

Basis spread on variable rate

1.00%

Amended and Restated Senior Credit Facility [Member] | Base Rate Loans [Member]

Debt Instrument [Line Items]

Interest on borrowings

2.25%

Basis spread on variable rate

0.50%

Amended and Restated Senior Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]

Debt Instrument [Line Items]

Interest on borrowings

3.25%

Amended and Restated Senior Credit Facility [Member] | Senior Debt Obligations [Member] | First Incremental Amendment [Member]

Debt Instrument [Line Items]

Date entered into an agreement

Feb. 11, 2015

Line of credit

$ 500,000,000

Amended and Restated Senior Credit Facility [Member] | June 30, 2015 to December 31, 2015 [Member]

Debt Instrument [Line Items]

Term loan principal repayments

6,700,000

Term loan repayments

$ 1,300,000

Amended and Restated Senior Credit Facility [Member] | March 31, 2016 to December 31, 2016 [Member]

Debt Instrument [Line Items]

Term loan principal repayments

10,000,000

Term loan repayments

$ 1,300,000

Amended and Restated Senior Credit Facility [Member] | March 31, 2017 to December 31, 2017 [Member]

Debt Instrument [Line Items]

Term loan principal repayments

13,400,000

Term loan repayments

$ 1,300,000

Amended and Restated Senior Credit Facility [Member] | March 31, 2018 to December 31, 2018 [Member]

Debt Instrument [Line Items]

Term loan principal repayments

16,700,000

Amended and Restated Senior Credit Facility [Member] | CRC Health Group, Inc [Member] | Senior Secured Revolving Line of Credit [Member]

Debt Instrument [Line Items]

Temporary reserve

$ 110,000,000

Long-Term Debt (12.875% Senior

Long-Term Debt (12.875% Senior Notes due 2018) - Additional Information (Detail) - 12.875% Senior Notes Due 2018 [Member] - USD ($) $ in Thousands	Mar. 12, 2013	Jun. 30, 2015	Dec. 31, 2014	Nov. 01, 2011
Debt Instrument [Line Items]
Issued Senior Notes				$ 150,000
Issue rate of senior notes				98.323%
Debt instrument discount		$ 967	$ 1,080	$ 2,500
Senior notes interest percentage	12.875%	12.875%	12.875%	12.875%
Interest on the notes		Semi-annually, in arrears, on November 1 and May 1 of each year
Debt instrument, maximum redemption amount	$ 52,500
Debt instrument, redemption price percentage	112.875%
Redemption percentage of senior notes	35.00%
Debt extinguishment charge	$ 9,400

Long-Term Debt (6.125% Senior N

Long-Term Debt (6.125% Senior Notes due 2021) - Additional Information (Detail) - 6.125% Senior Notes Due 2021 [Member] - USD ($) $ in Millions	Mar. 12, 2013	Jun. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Issued Senior Notes	$ 150
Debt instrument interest rate	6.125%	6.125%	6.125%
Debt instrument maturity date	Mar. 15, 2021
Interest on the notes		Payable semi-annually in arrears on March 15 and September 15 of each year.
Senior notes terms		The Company may redeem the 6.125% Senior Notes at its option, in whole or part, at any time prior to March 15, 2016, at a price equal to 100% of the principal amount of the 6.125% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. The Company may redeem the 6.125% Senior Notes, in whole or in part, on or after March 15, 2016, at the redemption prices set forth in the indenture governing the 6.125% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before March 15, 2016, the Company may elect to redeem up to 35% of the aggregate principal amount of the 6.125% Senior Notes at a redemption price equal to 106.125% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings.
Debt Instrument, Redemption, Period One [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage		100.00%
Debt Instrument, Redemption, Period Two [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage		106.125%
Redemption percentage of senior notes		35.00%
Redemption date		Mar. 15, 2016

Long-Term Debt (5.125% Senior N

Long-Term Debt (5.125% Senior Notes due 2022) - Additional Information (Detail) - 5.125% Senior Notes due 2022 [Member] - USD ($) $ in Millions	Jul. 01, 2014	Jun. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Issued Senior Notes	$ 300
Debt instrument interest rate	5.125%	5.125%	5.125%
Debt instrument maturity date	Jul. 1, 2022
Interest on the notes		Payable semi-annually in arrears on January 1 and July 1 of each year, beginning on January 1, 2015.
Senior notes terms		The Company may redeem the 5.125% Senior Notes at its option, in whole or part, at any time prior to July 1, 2017, at a price equal to 100% of the principal amount of the 5.125% Senior Notes redeemed, plus accrued and unpaid interest to the redemption date and plus an applicable premium. The Company may redeem the 5.125% Senior Notes, in whole or in part, on or after July 1, 2017, at the redemption prices set forth in the indenture governing the 5.125% Senior Notes plus accrued and unpaid interest to the redemption date. At any time on or before July 1, 2017, the Company may elect to redeem up to 35% of the aggregate principal amount of the 5.125% Senior Notes at a redemption price equal to 105.125% of the principal amount thereof, plus accrued and unpaid interest to the redemption date, with the net proceeds of one or more equity offerings.
Debt Instrument, Redemption, Period One [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage		100.00%
Debt Instrument, Redemption, Period Two [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage		105.125%
Redemption percentage of senior notes		35.00%
Redemption date		Jul. 1, 2017

Long-Term Debt (5.625% Senior N

Long-Term Debt (5.625% Senior Notes due 2023) - Additional Information (Detail) - 5.625% Senior Notes Due 2023 [Member] - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2015	Feb. 11, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Issued Senior Notes		$ 375
Debt instrument interest rate	5.625%	5.625%	5.625%
Debt instrument maturity date	Feb. 15, 2023
Date of initial payments on senior notes	Aug. 15, 2015
Debt Instrument, Redemption, Period One [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage	100.00%
Debt Instrument, Redemption, Period Two [Member]
Debt Instrument [Line Items]
Debt instrument, redemption price percentage	105.625%
Redemption percentage of senior notes	35.00%
Redemption date	Feb. 15, 2018

Long-Term Debt (9.0% and 9.5% R

Long-Term Debt (9.0% and 9.5% Revenue Bonds) - Additional Information (Detail) - 9.0% and 9.5% Revenue Bonds [Member] - USD ($) $ in Thousands	Nov. 11, 2012	Jun. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds		$ 24,054	$ 24,274
Debt instrument premium		1,429	1,649
Park Royal [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	$ 23,000
Debt service reserve fund within other assets		$ 2,300	$ 2,300
Debt instrument premium	2,600
Fair Value Measurement [Member] | Park Royal [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	25,600
9.0% Revenue Bonds [Member] | Park Royal [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	$ 7,500
Debt instrument interest rate	9.00%
Debt instrument maturity date	Dec. 1, 2030
9.5% Revenue Bonds [Member] | Park Royal [Member]
Debt Instrument [Line Items]
9.0% and 9.5% Revenue Bonds	$ 15,500
Debt instrument interest rate	9.50%
Debt instrument maturity date	Dec. 1, 2040

Equity Offerings - Additional I

Equity Offerings - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	May. 11, 2015	Feb. 11, 2015	Jun. 17, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Equity [Line Items]
Common stock offered	5,175,000		8,881,794	70,596,523		59,211,859
Common stock offer price	$ 66.50		$ 44	$ 0.01		$ 0.01
Underwriting discount amount	$ 12,000		$ 15,600
Additional offering-related costs	600		800
Net proceeds from sale of shares	$ 331,500		$ 374,400	$ 331,530	$ 374,336
CRC Health Group, Inc [Member]
Equity [Line Items]
Total consideration related to acquisition		$ 1,300,000
Shares issued for acquisition		5,975,326

Equity-Based Compensation - Add

Equity-Based Compensation - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized common stock	4,700,000		4,700,000
Equity incentive plan available for future grant	1,257,326		1,257,326
Annual increments in employee grants			25.00%
Stock options, contractual term			10 years
Equity-based compensation expense	$ 5,355	$ 2,406	$ 9,249	$ 4,170
Unrecognized compensation expense related to unvested options			$ 57,700
Vesting period			1 year 7 months 6 days
Warrants outstanding	0		0
Tax realized from stock options exercised	$ 2,000	800	$ 6,300	3,500
Stock Compensation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferred income tax benefit	$ 2,200	$ 1,000	$ 3,800	$ 1,700

Equity-Based Compensation - Sto

Equity-Based Compensation - Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Options outstanding, Beginning balance	737,422	798,809
Options granted	190,900	226,663
Options exercised	(49,045)	(210,199)
Options cancelled	(88,264)	(77,851)
Options outstanding, Ending balance	791,013	737,422	798,809
Options outstanding, Weighted Average Exercise Price, Beginning balance	$ 32.19	$ 21.93
Options exercisable, Ending balance	153,900	91,947
Options granted, Weighted Average Exercise Price	$ 62.37	$ 49.80
Options exercised, Weighted Average Exercise Price	23.66	14.93
Options cancelled, Weighted Average Exercise Price	47.86	27.85
Options outstanding, Weighted Average Exercise Price, Ending balance	$ 40.28	$ 32.19	$ 21.93
Options outstanding, Aggregate Intrinsic Value, Beginning balance	$ 14,512	$ 10,700
Options exercisable, Weighted Average Exercise Price, Ending balance	$ 34.84	$ 28.87
Options granted, Aggregate Intrinsic Value	$ 1,148	$ 209
Options granted, Weighted Average Remaining Contractual Term	9 years 8 months 5 days	9 years 3 months
Options exercised, Aggregate Intrinsic Value	$ 5,197	$ 4,994
Options outstanding, Weighted Average Remaining Contractual Term	8 years 1 month 2 days	8 years 1 month 2 days	8 years 2 months 12 days
Options cancelled, Aggregate Intrinsic Value	$ 0	$ 0
Options exercisable, Weighted Average Remaining Contractual Term, Ending balance	6 years 7 months 6 days	6 years 3 months 18 days
Options outstanding, Aggregate Intrinsic Value, Ending balance	$ 23,104	$ 14,512	$ 10,700
Options exercisable, Aggregate Intrinsic Value, Ending balance	$ 6,941	$ 3,326

Equity-Based Compensation - Res

Equity-Based Compensation - Restricted Stock Activity (Detail) - Restricted Stock Award [Member] - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested, Number of Shares/Units, Beginning balance	722,028	461,697
Granted, Number of Shares	480,152	468,484
Cancelled, Number of Shares	(55,674)	(75,369)
Vested, Number of Shares	(107,263)	(132,784)
Unvested, Number of Shares/Units, Ending balance	1,039,243	722,028
Unvested, Weighted Average Grant-Date Fair Value, Beginning balance	$ 39.77	$ 24.96
Granted, Weighted Average Grant-Date Fair Value	62.08	48.99
Cancelled, Weighted Average Grant-Date Fair Value	49.59	36.36
Vested, Weighted Average Grant-Date Fair Value	32.47	22.81
Unvested, Weighted Average Grant-Date Fair Value, Ending balance	$ 51.03	$ 39.77

Equity-Based Compensation - R61

Equity-Based Compensation - Restricted Stock Unit Activity (Detail) - Restricted Stock Units [Member] - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested, Number of Shares/Units, Beginning balance	125,113	95,751
Granted, Number of Units	217,994	108,449
Cancelled, Number of Units	0	0
Vested, Number of Units	(125,023)	(79,087)
Unvested, Number of Shares/Units, Ending balance	218,084	125,113
Unvested, Weighted Average Grant-Date Fair Value, Beginning balance	$ 38.73	$ 23.05
Granted, Weighted Average Grant-Date Fair Value	61.77	50.75
Cancelled, Weighted Average Grant-Date Fair Value	0	0
Vested, Weighted Average Grant-Date Fair Value	32.38	21.81
Unvested, Weighted Average Grant-Date Fair Value, Ending balance	$ 56.97	$ 38.73

Equity-Based Compensation - Sch

Equity-Based Compensation - Schedule of Stock Options Valuation Assumptions (Detail) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Weighted average grant-date fair value of options	$ 24.30	$ 17.14
Risk-free interest rate	1.90%	1.70%
Expected volatility	33.00%	36.00%
Expected life (in years)	5 years 6 months	5 years 6 months

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Income Tax Disclosure [Abstract]
Effective tax rates	31.40%	39.90%	31.40%	39.00%

Derivatives - Additional Inform

Derivatives - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Jul. 01, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
(Losses) gains associated with changes in fair value of the foreign currency forward contracts	$ (1)	$ 13.7	$ (0.9)	$ 13.7
Settlement of foreign currency forward contracts					$ 15.3

Fair Value Measurements - Carry

Fair Value Measurements - Carrying Amounts and Fair Values of Long-Term Debt and Contingent Consideration Liability (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
12.875% Senior Notes Due 2018 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	$ 96,533	$ 96,420
6.125% Senior Notes Due 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	150,000	150,000
5.125% Senior Notes due 2022 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	300,000	300,000
5.625% Senior Notes Due 2023 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	375,000
9.0% and 9.5% Revenue Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
9.0% and 9.5% Revenue Bonds	24,054	24,274
Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contingent consideration liabilities	3,000	3,000
Fair Value [Member] | Amended and Restated Senior Credit Facility [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amended and Restated Senior Credit Facility	1,007,620	525,576
Fair Value [Member] | 12.875% Senior Notes Due 2018 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	106,519	109,688
Fair Value [Member] | 6.125% Senior Notes Due 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	154,500	153,000
Fair Value [Member] | 5.125% Senior Notes due 2022 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	297,750	295,500
Fair Value [Member] | 5.625% Senior Notes Due 2023 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	379,688
Fair Value [Member] | 9.0% and 9.5% Revenue Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
9.0% and 9.5% Revenue Bonds	24,054	24,274
Carrying Amounts [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contingent consideration liabilities	3,000	3,000
Carrying Amounts [Member] | Amended and Restated Senior Credit Facility [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amended and Restated Senior Credit Facility	1,007,620	525,576
Carrying Amounts [Member] | 12.875% Senior Notes Due 2018 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	96,533	96,420
Carrying Amounts [Member] | 6.125% Senior Notes Due 2021 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	150,000	150,000
Carrying Amounts [Member] | 5.125% Senior Notes due 2022 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	300,000	300,000
Carrying Amounts [Member] | 5.625% Senior Notes Due 2023 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	375,000
Carrying Amounts [Member] | 9.0% and 9.5% Revenue Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
9.0% and 9.5% Revenue Bonds	$ 24,054	$ 24,274

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($) $ in Thousands	6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Jul. 01, 2014	Mar. 12, 2013	Nov. 01, 2011
Disclosures Regarding Financial Instruments [Line Items]
Contingent consideration, Paid		$ 3,250
Park Royal [Member]
Disclosures Regarding Financial Instruments [Line Items]
Increase (Decrease) in fair value of contingent consideration liability	$ 500
Contingent consideration, Paid			$ 5,000
Contingent consideration liabilities			7,000
McCallum [Member]
Disclosures Regarding Financial Instruments [Line Items]
Cash payments for earn-out agreement			$ 6,000
12.875% Senior Notes Due 2018 [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	12.875%		12.875%		12.875%	12.875%
6.125% Senior Notes Due 2021 [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	6.125%		6.125%		6.125%
5.125% Senior Notes due 2022 [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	5.125%		5.125%	5.125%
5.625 % Senior Notes Due 2021 [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	5.625%
9.0% Revenue Bonds [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	9.00%		9.00%
9.5% Revenue Bonds [Member]
Disclosures Regarding Financial Instruments [Line Items]
Debt instrument interest rate	9.50%		9.50%

Segment Information - Additiona

Segment Information - Additional Information (Detail) - Jun. 30, 2015	BedsStateFacilities
Segment Reporting Information [Line Items]
Number of facilities	223
Number of beds | Beds	9,000
Number of operating states | State	37
U.S. Facilities [Member]
Segment Reporting Information [Line Items]
Number of facilities	178
Number of operating states | State	37
U.S. Facilities [Member] | Minimum [Member]
Segment Reporting Information [Line Items]
Number of beds | Beds	7,200
U.K. Facilities [Member]
Segment Reporting Information [Line Items]
Number of facilities	45
U.K. Facilities [Member] | Minimum [Member]
Segment Reporting Information [Line Items]
Number of beds | Beds	1,800

Segment Information - Summary o

Segment Information - Summary of Financial Information by Operating Segment (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Segment Reporting Information [Line Items]
Revenue	$ 453,660	$ 213,803	$ 819,443	$ 415,221
Segment EBITDA	105,803	44,714	184,515	83,996
Equity-based compensation expense	(5,355)	(2,406)	(9,249)	(4,170)
(Loss) gain on foreign currency derivatives	(961)	13,735	(908)	13,735
Transaction-related expenses	(7,157)	(3,016)	(25,573)	(4,595)
Interest expense, net	(28,049)	(9,730)	(50,195)	(19,437)
Depreciation and amortization	(14,926)	(5,935)	(28,030)	(11,371)
Income from continuing operations before income taxes	49,355	37,362	70,560	58,158
U.S. Facilities [Member]
Segment Reporting Information [Line Items]
Revenue	366,886	212,834	657,393	413,398
Segment EBITDA	102,342	53,031	178,706	100,563
U.K. Facilities [Member]
Segment Reporting Information [Line Items]
Revenue	84,927		158,242
Segment EBITDA	20,371		39,182
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Revenue	1,847	969	3,808	1,823
Segment EBITDA	$ (16,910)	$ (8,317)	$ (33,373)	$ (16,567)

Segment Information - Summary69

Segment Information - Summary of Financial Information by Operating Segment, Goodwill (Detail) $ in Thousands	6 Months Ended
	Jun. 30, 2015USD ($)
Goodwill:
Beginning balance	$ 802,986
Increase from 2015 acquisitions	1,169,106
Foreign currency translation	6,972
Purchase price allocation and other	(33,036)
Ending balance	1,946,028
U.S. Facilities [Member]
Goodwill:
Beginning balance	693,945
Increase from 2015 acquisitions	1,103,813
Purchase price allocation and other	281
Ending balance	1,798,039
U.K. Facilities [Member]
Goodwill:
Beginning balance	109,041
Increase from 2015 acquisitions	65,293
Foreign currency translation	6,972
Purchase price allocation and other	(33,317)
Ending balance	$ 147,989

Segment Information - Summary70

Segment Information - Summary of Financial Information by Operating Segment, Assets (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Assets
Assets	$ 3,926,385	$ 2,223,590
U.S. Facilities [Member]
Assets
Assets	2,729,896	1,327,563
U.K. Facilities [Member]
Assets
Assets	944,033	726,693
Corporate and Other [Member]
Assets
Assets	$ 252,456	$ 169,334

Segment Information - Summary71

Segment Information - Summary of Financial Information by Operating Segment, Assets (Parenthetical) (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	$ 1,455,390	$ 1,069,700
U.S. Facilities [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	671,200	478,100
U.K. Facilities [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	754,200	578,600
Corporate and Other [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	$ 30,000	$ 13,000

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - Jul. 01, 2015 - Subsequent Event [Member] $ in Millions	USD ($)Beds
United Kingdom [Member]
Subsequent Event [Line Items]
Number of beds | Beds	15
Business acquisition cash paid	$ 5.9
Pennsylvania [Member]
Subsequent Event [Line Items]
Number of beds | Beds	147
Business acquisition cash paid	$ 40
Total consideration related to acquisition	35
Estimated working capital settlement	$ 5

Financial Information for the73

Financial Information for the Company and Its Subsidiaries - Additional Information (Detail)	Jun. 30, 2015
12.875% Senior Notes Due 2018 [Member]
Line of Credit Facility [Line Items]
Debt instrument interest rate	12.875%
6.125% Senior Notes Due 2021 [Member]
Line of Credit Facility [Line Items]
Debt instrument interest rate	6.125%
5.125% Senior Notes due 2022 [Member]
Line of Credit Facility [Line Items]
Debt instrument interest rate	5.125%
5.625% Senior Notes Due 2023 [Member]
Line of Credit Facility [Line Items]
Debt instrument interest rate	5.625%

Financial Information for the74

Financial Information for the Company and Its Subsidiaries - Summary of Condensed Consolidating Balance Sheets (Detail) - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014	Jun. 30, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 34,572	$ 94,040	$ 277,744	$ 4,569
Accounts receivable, net	182,315	118,378
Deferred tax assets	38,693	20,155
Other current assets	70,325	41,570
Total current assets	325,905	274,143
Property and equipment, net	1,455,390	1,069,700
Goodwill	1,946,028	802,986
Intangible assets, net	58,514	21,636
Deferred tax assets - noncurrent	33,966	13,141
Other assets	106,582	41,984
Total assets	3,926,385	2,223,590
Current liabilities:
Current portion of long-term debt	38,652	26,965
Accounts payable	58,714	48,696
Accrued salaries and benefits	77,545	59,317
Other accrued liabilities	68,197	30,956
Total current liabilities	243,108	165,934
Long-term debt	1,914,555	1,069,305
Deferred tax liabilities - noncurrent	20,200	63,880
Other liabilities	82,218	43,506
Total liabilities	2,260,081	1,342,625
Total equity	1,666,304	880,965
Total liabilities and equity	3,926,385	2,223,590
Consolidating Adjustments [Member]
Current assets:
Cash and cash equivalents				(1,925)
Deferred tax assets - noncurrent		(5,666)
Investment in subsidiaries	(1,332,308)	(1,759,337)
Other assets	(351,373)	(181,774)
Total assets	(1,683,681)	(1,946,777)
Current liabilities:
Long-term debt	(351,373)	(181,774)
Deferred tax liabilities - noncurrent		(5,666)
Total liabilities	(351,373)	(187,440)
Total equity	(1,332,308)	(1,759,337)
Total liabilities and equity	(1,683,681)	(1,946,777)
Parent [Member]
Current assets:
Deferred tax assets - noncurrent	5,361	4,563
Investment in subsidiaries	1,332,308	1,759,337
Other assets	389,676	202,708
Total assets	1,727,345	1,966,608
Current liabilities:
Current portion of long-term debt	38,437	26,750
Other accrued liabilities	22,604	13,647
Total current liabilities	61,041	40,397
Long-term debt		1,045,246
Total liabilities	61,041	1,085,643
Total equity	1,666,304	880,965
Total liabilities and equity	1,727,345	1,966,608
Combined Subsidiary Guarantors [Member]
Current assets:
Cash and cash equivalents	17,179	76,685	274,517
Accounts receivable, net	160,179	100,797
Deferred tax assets	36,502	18,395
Other current assets	62,295	36,049
Total current assets	276,155	231,926
Property and equipment, net	656,262	451,943
Goodwill	1,700,705	596,611
Intangible assets, net	55,928	19,057
Deferred tax assets - noncurrent	16,239
Other assets	65,957	18,727
Total assets	2,771,246	1,318,264
Current liabilities:
Accounts payable	44,985	39,486
Accrued salaries and benefits	65,040	47,597
Other accrued liabilities	27,543	7,688
Total current liabilities	137,568	94,771
Long-term debt	1,890,716
Deferred tax liabilities - noncurrent		21,027
Other liabilities	72,329	33,321
Total liabilities	2,100,613	149,119
Total equity	670,633	1,169,145
Total liabilities and equity	2,771,246	1,318,264
Combined Non-Guarantors [Member]
Current assets:
Cash and cash equivalents	17,393	17,355	$ 3,227	$ 6,494
Accounts receivable, net	22,136	17,581
Deferred tax assets	2,191	1,760
Other current assets	8,030	5,521
Total current assets	49,750	42,217
Property and equipment, net	799,128	617,757
Goodwill	245,323	206,375
Intangible assets, net	2,586	2,579
Deferred tax assets - noncurrent	12,366	14,244
Other assets	2,322	2,323
Total assets	1,111,475	885,495
Current liabilities:
Current portion of long-term debt	215	215
Accounts payable	13,729	9,210
Accrued salaries and benefits	12,505	11,720
Other accrued liabilities	18,050	9,621
Total current liabilities	44,499	30,766
Long-term debt	375,212	205,833
Deferred tax liabilities - noncurrent	20,200	48,519
Other liabilities	9,889	10,185
Total liabilities	449,800	295,303
Total equity	661,675	590,192
Total liabilities and equity	$ 1,111,475	$ 885,495

Financial Information for the75

Financial Information for the Company and Its Subsidiaries - Summary of Condensed Consolidating Statement of Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Condensed Financial Statements, Captions [Line Items]
Revenue before provision for doubtful accounts	$ 461,798	$ 220,664	$ 835,956	$ 426,783
Provision for doubtful accounts	(8,138)	(6,861)	(16,513)	(11,562)
Revenue	453,660	213,803	819,443	415,221
Salaries, wages and benefits	243,302	122,473	449,173	240,048
Professional fees	30,029	10,891	52,456	21,273
Supplies	20,542	10,596	36,796	20,660
Rents and leases	8,211	2,889	14,097	5,658
Other operating expenses	51,128	24,646	91,655	47,756
Depreciation and amortization	14,926	5,935	28,030	11,371
Interest expense, net	28,049	9,730	50,195	19,437
Loss (gain) on foreign currency derivatives	961	(13,735)	908	(13,735)
Transaction-related expenses	7,157	3,016	25,573	4,595
Total expenses	404,305	176,441	748,883	357,063
(Loss) income from continuing operations before income taxes	49,355	37,362	70,560	58,158
(Benefit from) provision for income taxes	15,512	14,905	22,125	22,680
Income (loss) from continuing operations	33,843	22,457	48,435	35,478
Income (loss) from discontinued operations, net of income taxes	1	(6)	3	31
Net income (loss)	33,844	22,451	48,438	35,509
Other comprehensive income:
Foreign currency translation gain	46,173		16,784
Other comprehensive income	46,173		16,784
Comprehensive income (loss)	80,017	22,451	65,222	35,509
Consolidating Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Equity in earnings of subsidiaries	(50,281)	(20,972)	(76,268)	(40,839)
Income (loss) from continuing operations	(50,281)	(20,972)	(76,268)	(40,839)
Net income (loss)	(50,281)	(20,972)	(76,268)	(40,839)
Other comprehensive income:
Comprehensive income (loss)	(50,281)	(20,972)	(76,268)	(40,839)
Parent [Member]
Condensed Financial Statements, Captions [Line Items]
Salaries, wages and benefits	5,355	2,406	9,249	4,170
Interest expense, net	18,106	9,202	31,054	18,313
Loss (gain) on foreign currency derivatives	961	(13,735)	908	(13,735)
Total expenses	24,422	(2,127)	41,211	8,748
(Loss) income from continuing operations before income taxes	(24,422)	2,127	(41,211)	(8,748)
Equity in earnings of subsidiaries	50,281	20,972	76,268	40,839
(Benefit from) provision for income taxes	(7,985)	648	(13,381)	(3,418)
Income (loss) from continuing operations	33,844	22,451	48,438	35,509
Net income (loss)	33,844	22,451	48,438	35,509
Other comprehensive income:
Comprehensive income (loss)	33,844	22,451	48,438	35,509
Combined Subsidiary Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Revenue before provision for doubtful accounts	363,851	207,143	651,616	400,425
Provision for doubtful accounts	(7,566)	(5,954)	(14,985)	(10,464)
Revenue	356,285	201,189	636,631	389,961
Salaries, wages and benefits	183,490	114,976	339,189	225,629
Professional fees	22,579	9,691	39,064	18,944
Supplies	16,929	9,967	29,938	19,353
Rents and leases	7,402	2,613	12,519	5,108
Other operating expenses	43,145	22,522	75,392	43,600
Depreciation and amortization	10,551	5,581	19,262	10,666
Interest expense, net	5,882		11,603
Transaction-related expenses	2,946	3,016	21,362	4,595
Total expenses	292,924	168,366	548,329	327,895
(Loss) income from continuing operations before income taxes	63,361	32,823	88,302	62,066
(Benefit from) provision for income taxes	20,734	13,315	29,251	24,249
Income (loss) from continuing operations	42,627	19,508	59,051	37,817
Income (loss) from discontinued operations, net of income taxes	1	(6)	3	31
Net income (loss)	42,628	19,502	59,054	37,848
Other comprehensive income:
Comprehensive income (loss)	42,628	19,502	59,054	37,848
Combined Non-Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Revenue before provision for doubtful accounts	97,947	13,521	184,340	26,358
Provision for doubtful accounts	(572)	(907)	(1,528)	(1,098)
Revenue	97,375	12,614	182,812	25,260
Salaries, wages and benefits	54,457	5,091	100,735	10,249
Professional fees	7,450	1,200	13,392	2,329
Supplies	3,613	629	6,858	1,307
Rents and leases	809	276	1,578	550
Other operating expenses	7,983	2,124	16,263	4,156
Depreciation and amortization	4,375	354	8,768	705
Interest expense, net	4,061	528	7,538	1,124
Transaction-related expenses	4,211		4,211
Total expenses	86,959	10,202	159,343	20,420
(Loss) income from continuing operations before income taxes	10,416	2,412	23,469	4,840
(Benefit from) provision for income taxes	2,763	942	6,255	1,849
Income (loss) from continuing operations	7,653	1,470	17,214	2,991
Net income (loss)	7,653	1,470	17,214	2,991
Other comprehensive income:
Foreign currency translation gain	46,173		16,784
Other comprehensive income	46,173		16,784
Comprehensive income (loss)	$ 53,826	$ 1,470	$ 33,998	$ 2,991

Financial Information for the76

Financial Information for the Company and Its Subsidiaries - Summary of Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Operating activities:
Net income (loss)	$ 33,844	$ 22,451	$ 48,438	$ 35,509
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Depreciation and amortization	14,926	5,935	28,030	11,371
Amortization of debt issuance costs			3,218	1,334
Equity-based compensation expense	5,355	2,406	9,249	4,170
Deferred income tax (benefit) expense			24,682	9,097
Income (loss) from discontinued operations, net of income taxes	(1)	6	(3)	(31)
Loss (gain) on foreign currency derivatives	961	(13,735)	908	(13,735)
Other			692	25
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net			(10,442)	(15,303)
Other current assets			(13,048)	(4,792)
Other assets			(1,218)	(578)
Accounts payable and other accrued liabilities			(4,313)	(1,300)
Accrued salaries and benefits			(225)	1,782
Other liabilities			4,619	1,701
Net cash provided by continuing operating activities			90,587	29,250
Net cash provided by discontinued operating activities			554	(11)
Net cash (used in) provided by operating activities			91,141	29,239
Investing activities:
Cash paid for acquisitions, net of cash acquired			(286,734)	(10,000)
Cash paid for capital expenditures			(122,035)	(43,323)
Cash paid for real estate acquisitions			(3,428)	(18,326)
Settlement of foreign currency derivatives			(908)
Other			(481)	(439)
Net cash used in investing activities			(413,586)	(72,088)
Financing activities:
Borrowings on long-term debt			875,000	7,500
Borrowings on revolving credit facility			180,000	59,500
Principal payments on revolving credit facility			(180,000)	(113,000)
Repayment of assumed CRC debt			(904,467)
Principal payments on long-term debt			(15,875)	(3,750)
Payment of debt issuance costs			(22,775)	(5,810)
Issuance of common stock, net			(380,210)	374,336
Common stock withheld for minimum statutory taxes, net			(7,826)	(2,981)
Excess tax benefit from equity awards			6,327	3,479
Other			(150)
Cash paid for contingent consideration				(3,250)
Net cash provided by (used in) financing activities			261,764	316,024
Effect of exchange rate changes on cash			1,213
Net (decrease) increase in cash and cash equivalents			(59,468)	273,175
Cash and cash equivalents at beginning of the period			94,040	4,569	$ 4,569
Cash and cash equivalents at end of the period	34,572	277,744	34,572	277,744	94,040
Consolidating Adjustments [Member]
Operating activities:
Net income (loss)	(50,281)	(20,972)	(76,268)	(40,839)
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries	50,281	20,972	76,268	40,839
Change in operating assets and liabilities, net of effect of acquisitions:
Other assets			300	(165)
Net cash provided by continuing operating activities			300	(165)
Net cash (used in) provided by operating activities			300	(165)
Financing activities:
Principal payments on long-term debt			300	165
Cash provided by (used in) intercompany activity			(600)	1,925
Net cash provided by (used in) financing activities			(300)	2,090
Net (decrease) increase in cash and cash equivalents				1,925
Cash and cash equivalents at beginning of the period				(1,925)	(1,925)
Parent [Member]
Operating activities:
Net income (loss)	33,844	22,451	48,438	35,509
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Equity in earnings of subsidiaries	(50,281)	(20,972)	(76,268)	(40,839)
Amortization of debt issuance costs				1,560
Equity-based compensation expense			9,249	4,170
Deferred income tax (benefit) expense			(798)	5,585
Loss (gain) on foreign currency derivatives	961	(13,735)	908	(13,735)
Change in operating assets and liabilities, net of effect of acquisitions:
Other assets			(300)	165
Net cash provided by continuing operating activities			(18,771)	(7,585)
Net cash (used in) provided by operating activities			(18,771)	(7,585)
Financing activities:
Borrowings on long-term debt			875,000	7,500
Borrowings on revolving credit facility			180,000	59,500
Principal payments on revolving credit facility			(180,000)	(113,000)
Repayment of assumed CRC debt			(904,467)
Principal payments on long-term debt			(15,875)	(3,750)
Payment of debt issuance costs				(5,810)
Issuance of common stock, net				374,336
Common stock withheld for minimum statutory taxes, net				(2,981)
Excess tax benefit from equity awards				3,479
Cash provided by (used in) intercompany activity			64,113	(311,689)
Net cash provided by (used in) financing activities			18,771	7,585
Combined Subsidiary Guarantors [Member]
Operating activities:
Net income (loss)	42,628	19,502	59,054	37,848
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Depreciation and amortization	10,551	5,581	19,262	10,666
Amortization of debt issuance costs			3,438
Deferred income tax (benefit) expense			22,964	3,105
Income (loss) from discontinued operations, net of income taxes	(1)	6	(3)	(31)
Other			662	25
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net			(11,409)	(16,670)
Other current assets			(12,026)	(5,033)
Other assets			(1,220)	(578)
Accounts payable and other accrued liabilities			5,991	(1,584)
Accrued salaries and benefits			791	1,701
Other liabilities			5,442	1,701
Net cash provided by continuing operating activities			92,946	31,150
Net cash provided by discontinued operating activities			554	(11)
Net cash (used in) provided by operating activities			93,500	31,139
Investing activities:
Cash paid for acquisitions, net of cash acquired			(89,041)	(10,000)
Cash paid for capital expenditures			(62,101)	(39,782)
Cash paid for real estate acquisitions			(3,428)	(18,326)
Settlement of foreign currency derivatives			(908)
Other			(481)	(439)
Net cash used in investing activities			(155,959)	(68,547)
Financing activities:
Payment of debt issuance costs			(22,775)
Issuance of common stock, net			331,530
Common stock withheld for minimum statutory taxes, net			(7,826)
Excess tax benefit from equity awards			6,327
Other			(150)
Cash paid for contingent consideration				(3,250)
Cash provided by (used in) intercompany activity			(305,366)	315,175
Net cash provided by (used in) financing activities			1,740	311,925
Effect of exchange rate changes on cash			1,213
Net (decrease) increase in cash and cash equivalents			(59,506)	274,517
Cash and cash equivalents at beginning of the period			76,685
Cash and cash equivalents at end of the period	17,179	274,517	17,179	274,517	76,685
Combined Non-Guarantors [Member]
Operating activities:
Net income (loss)	7,653	1,470	17,214	2,991
Adjustments to reconcile net income (loss) to net cash (used in) provided by continuing operating activities:
Depreciation and amortization	4,375	354	8,768	705
Amortization of debt issuance costs			(220)	(226)
Deferred income tax (benefit) expense			2,516	407
Other			30
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net			967	1,367
Other current assets			(1,022)	241
Other assets			2
Accounts payable and other accrued liabilities			(10,304)	284
Accrued salaries and benefits			(1,016)	81
Other liabilities			(823)
Net cash provided by continuing operating activities			16,112	5,850
Net cash (used in) provided by operating activities			16,112	5,850
Investing activities:
Cash paid for acquisitions, net of cash acquired			(197,693)
Cash paid for capital expenditures			(59,934)	(3,541)
Net cash used in investing activities			(257,627)	(3,541)
Financing activities:
Principal payments on long-term debt			(300)	(165)
Cash provided by (used in) intercompany activity			241,853	(5,411)
Net cash provided by (used in) financing activities			241,553	(5,576)
Net (decrease) increase in cash and cash equivalents			38	(3,267)
Cash and cash equivalents at beginning of the period			17,355	6,494	6,494
Cash and cash equivalents at end of the period	$ 17,393	$ 3,227	$ 17,393	$ 3,227	$ 17,355